Top ▲

GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

The IUPHAR/BPS Guide to PHARMACOLOGY complete ligand list

Click here for help
Ligands specifically tagged as being of relevance to immunopharmacology & the Guide to IMMUNOPHARMACOLOGY.
Download as CSV

A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  

Ligand name ID Synonyms
A Back to top
852A Immunopharmacology Ligand 9025
A286982 Immunopharmacology Ligand 6592 A 286982, A-286982
A438079 Immunopharmacology Ligand 4118 A 438079, A-438079
AB928 PDB Ligand Immunopharmacology Ligand 11154 AB-928
abatacept Approved drug Immunopharmacology Ligand 6891 BMS-188667, CTLA4-IgG4m, Orencia®, RG-1046, RG-2077
ABBV-3373 Immunopharmacology Ligand 12917 ADC 122
abediterol Immunopharmacology Ligand 9326 LAS-100977
AbGn-168H Immunopharmacology Ligand 10013 AbGn-168, neihulizumab
abrezekimab Immunopharmacology Ligand 9806 CDP7766, UCB-4144, UCB4144, VR-942
abrilumab Immunopharmacology Ligand 11531 AMG 181, AMG-181, MEDI-7183, MEDI7183
abrocitinib Approved drug PDB Ligand Immunopharmacology Ligand 9991 Cibinqo®, compound 25 [PMID: 29298069], PF-04965842, PF04965842
abscisic acid Immunopharmacology Ligand 10362 (+/-)-(cis,trans)-abscisic acid, (+/-)-Abscisic acid, (RS)-Abscisic acid, ABA
ABT-737 PDB Ligand Immunopharmacology Ligand 8320 ABT 737, ABT737, compound 2 [PMID 17256834]
AC430 Immunopharmacology Ligand 9177 AC-430
acalabrutinib Approved drug PDB Ligand Immunopharmacology Ligand 8912 ACP-196, Calquence®, Example 6 [US20140155385 A1]
Ac-SDKP Immunopharmacology Ligand 10060 goralatide, seraspenide
ACT-1014-6470 Immunopharmacology Ligand 12326 example 172 [WO2019137927A1], Ic-58
ACT-389949 Immunopharmacology Ligand 9511
ACT-660602 Immunopharmacology Ligand 12207 ACT660602, compound 9j [PMID: 35947786]
ACT-777991 Immunopharmacology Ligand 12584 ACT777991, compound 8a [PMID: 36883854]
ACTH Approved drug Immunopharmacology Ligand 3633 Acthar®, adrenocorticotropic hormone (1-39), corticotropin
acumapimod Immunopharmacology Ligand 9203 BCT 197, BCT-197, BCT197, compound A [WO2013139809]
adalimumab Approved drug Immunopharmacology Ligand 4860 D2E7, Humira®
(-)-adrenaline Approved drug PDB Ligand Immunopharmacology Ligand 479 adrenalin, Auvi-Q®, Epipen®, l-adrenaline, L-epinephrine, levoepinephrine
adrenomedullin Immunopharmacology Ligand 683 AM
adriforant Immunopharmacology Ligand 8985 PF 3893787, PF-03893787, ZPL-389, ZPL-3893787, ZPL389, ZPL3893787
ADU-S100 Immunopharmacology Ligand 10192 dithio-(Rp,Rp)-[cyclic[A(2',5')pA(3',5')p]], MIW815, ML RR-S2 CDA, S100
AF12198 Immunopharmacology Ligand 4861 AF 12198, AF-12198
AFM13 Immunopharmacology Ligand 10067 AFM 13, AFM-13
agatolimod Immunopharmacology Ligand 9843 CpG 7909, CpG7909, PF 3512676, PF-3512676, ProMune, VaxImmune
AGU654 Immunopharmacology Ligand 13646 AGU-654, compound 44 [PMID: 39622054]
AH10-7 Immunopharmacology Ligand 9899
AH6809 Immunopharmacology Ligand 1896 AH 6809, AH-6809
AJ2-30 Immunopharmacology Ligand 13090 compound 4 [PMID: 38191941]
AL-78898A Immunopharmacology Ligand 9219 4(1MeW), POT-4
alcaftadine Approved drug Immunopharmacology Ligand 7587 Lastacaft®, R-89674
alefacept Approved drug Immunopharmacology Ligand 6787 Amevive®, BG 9273, BG 9712, BG-9273, BG-9712, Lfa3Tip
alemtuzumab Approved drug Immunopharmacology Ligand 6770 campath 1H, Campath®, campath-1H, Lemtrada®
alimemazine Approved drug Immunopharmacology Ligand 7237 Nedeltran®, trimeprazine
3 alpha-aminocholestane Immunopharmacology Ligand 9564 3AC, 3 α-aminocholestane
ALT-803 Immunopharmacology Ligand 9615 IL-15 N72D:IL-15RαSu/Fc, IL-15SA, N-803
alvelestat Immunopharmacology Ligand 6476 AZD 9668, AZD-9668, AZD9668, KB-105160
AM-461 Immunopharmacology Ligand 10170 AM461, Compound 1 [WO2011085033]
AM-6120 Immunopharmacology Ligand 10119 AM6120, peptide 41 [PMID: 30346167]
amcinonide Approved drug Immunopharmacology Ligand 7060 CL-34699, Cyclocort®
amelenodor Immunopharmacology Ligand 13384 example 2 [WO2020010132A1], NX-13, NX13
amelubant Immunopharmacology Ligand 8463 BIIL 284, BIIL-284
AMG319 PDB Ligand Immunopharmacology Ligand 8917 AMG 319, AMG-319
AMG487 Immunopharmacology Ligand 13071 AMG 487, AMG-487, compound 47 [PMID: 17448658]
AMG820 Immunopharmacology Ligand 9106
aminopyridine 2 Immunopharmacology Ligand 10051
amiselimod Immunopharmacology Ligand 9319 Example 1 [US20090137530], MT-1303, MT1303
amiselimod phosphate Immunopharmacology Ligand 9491 amiselimod-P, MT-1303-P
amlexanox Approved drug PDB Ligand Immunopharmacology Ligand 7113 AA-673, Amlexanox®, Aphthasol®, CHX-3673
amphiregulin Immunopharmacology Ligand 4864 colorectal cell-derived growth factor (CRDGF)
AMT-101 Immunopharmacology Ligand 11645
AMY109 Immunopharmacology Ligand 12789 AMY-109, H1009/L395-F1974m
anakinra Approved drug Immunopharmacology Ligand 6972 antril, Kineret®
anatumomab mafenatox Immunopharmacology Ligand 9947 5T4FabV13SEAD227A, ABR 214936, ABR-214936, ABR214936, pMB125, PNU 214936, PNU-214936, PNU214936, TTS-CD2
ancriviroc Immunopharmacology Ligand 804 SCH 351125, SCH-351125, SCH-C
andecaliximab Immunopharmacology Ligand 9510 GS-5745, GS5745
andrographolide Immunopharmacology Ligand 9675
anifrolumab Approved drug Immunopharmacology Ligand 8258 anifrolumab-fnia, MDX-1333, MEDI-546, Saphnelo®
anti-FXII nanobody N4-38 Immunopharmacology Ligand 13274
apafant Immunopharmacology Ligand 1860 WEB 2086 BS, WEB-2086
APB-R3 Immunopharmacology Ligand 13869
apilimod Immunopharmacology Ligand 9859 LAM-002A (apilimod dimesylate), LAM002A, STA 5326, STA-5326, STA5326
apratastat Immunopharmacology Ligand 6482 compound 5h [PMID: 16426848], TMI-05, TMI005
apremilast Approved drug PDB Ligand Immunopharmacology Ligand 7372 CC-10004, Otezla®
APRIL Immunopharmacology Ligand 5068 A proliferation-inducing ligand, TALL2, TNF- and APOL-related leukocyte expressed ligand 2, TNF-related death ligand 1, TRDL-1, ZTNF2
Apta-1 Immunopharmacology Ligand Antimalarial Ligand 13556
AR-9281 Immunopharmacology Ligand 13112 AR9281, compound 14a [PMID: 21211973]
arformoterol Approved drug PDB Ligand Immunopharmacology Ligand 7479 (-)-Formoterol, (R,R)-Formoterol, Brovana®, YM-08316
ARN19702 PDB Ligand Immunopharmacology Ligand 10120 ARN-19702, compound 8 [PMID: 27404798]
ARN726 Immunopharmacology Ligand 9178 ARN-726, compound 6 [PMID: 25874594]
(R)-ARN2508 Immunopharmacology Ligand 9000 compound (-)-10r [PMID: 26774927], example 19 [WO2014023643]
(S)-ARN2508 PDB Ligand Immunopharmacology Ligand 8999 compound (+)-10r [PMID: 26774927], example 20 [WO2014023643]
arpromidine Immunopharmacology Ligand 1221 ARP
ARRY-371797 Immunopharmacology Ligand 11095 ARRY-797, ARRY371797, ARRY797, compound 7 [PMID: 19950901]
ARRY-382 Immunopharmacology Ligand 9108 ARRY 382, ARRY382, c-Fms-IN-12, PF-07265804, PF07265804
ARRY-502 Immunopharmacology Ligand 10179 ARRY502, example 237, enantiomer 1 [WO2009158426A1]
AS101 Immunopharmacology Ligand 437 ammonium tri-chloro(dioxoethylene-O,O'-)tellurate, AS 101, AS-101
AS-252424 Immunopharmacology Ligand 10578 AS252424, compound 26 [PMID: 16789742]
asapiprant Immunopharmacology Ligand 11951 BGE-175, BGE175, example II-74 [US8153793B2], S-555739
asimadoline Immunopharmacology Ligand 9279 EMD 61 753, EMD 61753, EMD-61753
asivatrep Immunopharmacology Ligand 9621 Example 230 [US7858621], PAC-14028
ASP4058 Immunopharmacology Ligand 9569 ASP-4058
aspirin Approved drug PDB Ligand Immunopharmacology Ligand 4139 Acetophen®, acetylsalicylic acid, Aspirin®
aspirin-triggered resolvin D1 Immunopharmacology Ligand 6239 AT-Resolvin D1, AT-RvD1
AT38 Immunopharmacology Ligand 9020 [3-(aminocarbonyl)furoxan-4-yl]methyl salicylate
atacicept Immunopharmacology Ligand 9517 TACI-Fc, TACI-Ig
atezolizumab Approved drug Immunopharmacology Ligand 7990 MPDL3280A, Tecentriq®
ATI-50001 Immunopharmacology Ligand 12317 ATI-501, ATI50001, ATI501, example 103 [WO2007070872A1]
atibuclimab Immunopharmacology Ligand 11326 IC14
atracurium Approved drug Immunopharmacology Ligand 9537 atracurium besilate, atracurium dibesylate, BW 33A, Tracrium®
auranofin Approved drug Immunopharmacology Ligand 6306 MMV688978, Ridaura®, SK&F-39162, SK-39162
avacincaptad pegol Approved drug Immunopharmacology Ligand 12857 ARC-1905, ARC1905, Izervay®, Zimura
avacopan Approved drug PDB Ligand Immunopharmacology Ligand 9450 CCX-168, CCX168, Tavneos®
avadomide Immunopharmacology Ligand 10522 CC-122, CC122, Compound A [WO2014039960A1]
avapritinib Approved drug PDB Ligand Immunopharmacology Ligand 10368 Ayvakit®, Ayvakyt®, BLU-285, BLU285
avdoralimab Immunopharmacology Ligand 11345 anti-hC5aR-32F3A6 GL, IPH-5401, NN-8210, NNC-0215-0384
AVE 0991 Immunopharmacology Ligand 5579 AVE-0991, AVE0991
avelumab Approved drug Immunopharmacology Ligand 8735 Bavencio®, MSB-0010718C, MSB0010718C
AX-024 Immunopharmacology Ligand 11253 AX-24, AX024
AZ13102909 Immunopharmacology Ligand 9577 AZ909
AZ2 PDB Ligand Immunopharmacology Ligand 10233
AZ3246 PDB Ligand Immunopharmacology Ligand 13722 AZ-3246, compound 24 [PMID: 39928839]
AZ3451 PDB Ligand Immunopharmacology Ligand 9560
AZ7188 Immunopharmacology Ligand 9586
AZ8838 PDB Ligand Immunopharmacology Ligand 9585
azacitidine Approved drug PDB Ligand Immunopharmacology Ligand 6796 5-AZAC, 5-azacytidine, ladakamycin, Onureg®, Onureg® (CC-486; oral azacitidine), U-18496, Vidaza®
azapro-3 Immunopharmacology Ligand 9221
azatadine Approved drug Immunopharmacology Ligand 7119 Optimine®, SCH-10649
azathioprine Approved drug Immunopharmacology Ligand 7120 Azasan®, BW-57-322, Imuran®, Jayempi®
AZD0284 PDB Ligand Immunopharmacology Ligand 11711 AZD-0284, compound 20 [PMID: 34464130]
AZD1236 Immunopharmacology Ligand 7844 AZD 1236, AZD-1236
AZD1678 Immunopharmacology Ligand 9679 AZD-1678, compound 49 [PMID: 28947948]
AZD1981 Immunopharmacology Ligand 7680 AZD 1981, AZD-1981
AZD2098 Immunopharmacology Ligand 9678 AZD-2098, compound 47 [PMID: 28947948]
AZD2423 Immunopharmacology Ligand 7825 AZD 2423, AZD-2423
AZD3458 Immunopharmacology Ligand 9997 AZD-3458, compound 15 [PMID: 29852070]
AZD3965 Immunopharmacology Ligand 10605 AZD-3965
AZD5069 Immunopharmacology Ligand 8948 AZD-5069
AZD5423 PDB Ligand Immunopharmacology Ligand 13017 AZD-5423, compound 1b [PMID: 28937774]
AZD5672 Immunopharmacology Ligand 7686 AZD 5672, AZD-5672
AZD5718 Immunopharmacology Ligand 10352 compound 12 [PMID: 30869888]
AZD6605 Immunopharmacology Ligand 7823 AZ 11920155, AZ-11920155, AZ11920155, AZD 6605, AZD-6605
AZD6703 PDB Ligand Immunopharmacology Ligand 7687 AZ 12012199, AZ-12012199, AZ12012199, AZD 6703, AZD-6703
AZD7624 Immunopharmacology Ligand 11714 AZD-7624, Example 259 [WO2009001132]
AZD8154 PDB Ligand Immunopharmacology Ligand 11204 AZD-8154, Example 1 [WO2018055040A1]
AZD8848 Immunopharmacology Ligand 9256 DSP-3025
AZD9056 Immunopharmacology Ligand 7826 AZD 9056, AZD-9056
AZD9567 PDB Ligand Immunopharmacology Ligand 9812 AZD 9567, AZD-9567, compound 15 [PMID: 29424542], example 1 [WO2016046260A1]
AZD9898 PDB Ligand Immunopharmacology Ligand 10479 AZD-9898, example 62 [WO2016177845A1]
azelaic acid Approved drug PDB Ligand Immunopharmacology Ligand 7484 Azelex®, Finacea®, ZK-62498
azithromycin Approved drug PDB Ligand Immunopharmacology Ligand Antimalarial Ligand 6510
AZ11657312 (salt free) Immunopharmacology Ligand 7722
 
B Back to top
bafetinib PDB Ligand Immunopharmacology Ligand 7906 INNO-406, Lyn-IN-1, NS-187
BAFF Immunopharmacology Ligand 5069 B cell-activating factor, CD257 antigen, dendritic cell-derived TNF-like molecule
baicalin PDB Ligand Immunopharmacology Ligand 13076 7-D-glucuronic acid-5,6-dihydroxy-flavone, Baicalein 7-glucuronide, compound 15 [PMID: 37666112]
balamapimod Immunopharmacology Ligand 9925 MKI-833, MKI833
balertatug Immunopharmacology Ligand 13800
balinatunfib Immunopharmacology Ligand 13583 SAR-441566, SAR441566
B and T lymphocyte attenuator Immunopharmacology Ligand 4891 BTLA, B- and T-lymphocyte attenuator , B- and T-lymphocyte-associated protein, CD272
bardoxolone Immunopharmacology Ligand 2717 CDDO, RTA-401
baricitinib Approved drug PDB Ligand Immunopharmacology Ligand 7792 INCB-028050, INCB028050, LY-3009104, LY3009104, Olumiant®
basiliximab Approved drug Immunopharmacology Ligand 6879 CHI-621, L04AC02, SDZ-CHI-621, Simulect®
batoclimab Immunopharmacology Ligand 13805 HBM9161, HL161, HL161ANS, IMVT-1401, RVT-1401
BAY 11-7082 Immunopharmacology Ligand 5934 (E)-3-tosylacrylonitrile, BAY-117082, BAY117082
BAY1830839 PDB Ligand Immunopharmacology Ligand 13101 BAY-1830839, example 11 [WO2016083433A1]
BAY-985 Immunopharmacology Ligand 10597 BAY985, compound 34 [PMID: 31859507]
BAYu9773 Immunopharmacology Ligand 3381 BAY u9773, BAY-u 9773
BC-1215 Immunopharmacology Ligand 12671 BC 1215, BC1215
beclometasone Approved drug PDB Ligand Immunopharmacology Ligand 7059 beclomethasone, SCH-18020W
beclometasone dipropionate Approved drug Immunopharmacology Ligand 5894 beclomethasone dipropionate, Beconase®, Qnasl®, Vancenase®
begelomab Immunopharmacology Ligand 8691 Begendina&rg; (proprietary name), BT 5/9, SAND 26
belantamab mafodotin Approved drug Immunopharmacology Ligand 11117 belamaf, belantamab mafodotin-blmf, Blenrep®, GSK-2857916, GSK2857916
belatacept Approved drug Immunopharmacology Ligand 6892 BMS-224818, LEA29Y, Nulojix®
belimumab Approved drug Immunopharmacology Ligand 6887 Benlysta®, hBlySmAb-1.1, LimphoStat-B, lymphostat-B
belnacasan Immunopharmacology Ligand 9035 HMR3480, VX-765
belumosudil Approved drug PDB Ligand Immunopharmacology Ligand 9558 KD-025, KD025, Rezurock®, SLx 2119, SLx2119
bempegaldesleukin Immunopharmacology Ligand 10659 NKTR-214, NKTR214
bempikibart Immunopharmacology Ligand 13725 ADX-914, ADX914
benralizumab Approved drug Immunopharmacology Ligand 7674 BIW-8405, Fasenra®, KHK4563, MEDI-563
bentamapimod Immunopharmacology Ligand 9926 AS-602801, AS602801, PGL-5001, PGL5001
benzodrocortisone Immunopharmacology Ligand 9731 compound 1 [WO2013071010], hydrocortisone 17-benzoate
3beta-Hydroxy-20(29)-lupene Immunopharmacology Ligand 9028 Fagarasterol, Lupeol
betamethasone Approved drug Immunopharmacology Ligand 7061 SCH-4831
bexmarilimab Immunopharmacology Ligand 12907 Clevegen, FP-1305, FP1305
bexobrutideg Immunopharmacology Ligand 12898 compound 195 [WO2021113557A1], NX-5948, NX5948
bezisterim Immunopharmacology Ligand 13988 17-ethynyl-5-androstene-3,7,17-triol, HE-3286, HE3286, NE-3107, NE3107
BI-1935 Immunopharmacology Ligand 9717 BI 1935, example 3 [WO2007067836]
BI-1950 Immunopharmacology Ligand 9719
BI-2545 PDB Ligand Immunopharmacology Ligand 9791 BI2545, compound 19 [PMID: 29259743]
BI605906 Immunopharmacology Ligand 9357 3-Amino-4-(1,1-difluoro- propyl)-6-(4-methanesulfonyl- piperidin-1-yl)-thieno[2,3- b]pyridine-2-carboxylic acid amide, compound 115 [US20070293533]
BI 653048 Immunopharmacology Ligand 9715 (R)-39, BI 653048 BS H3PO4, BI-653048, BI653048
BI 665915 Immunopharmacology Ligand 9716 BI-665915, compound 69 [PMID: 25671290]
BI-6901 Immunopharmacology Ligand 9714 BI 6901, BI 6901, BI6901, eut-22
bifikafusp alfa Immunopharmacology Ligand 9756 Daramun (bifikafusp alfa and onfekafusp alfa), Darleukin, L19-IL2, L19IL2, Nidlegy (bifikafusp alfa and onfekafusp alfa)
bihelical apoA-I mimetic peptide 5A Immunopharmacology Ligand 9183 5A peptide
BIIB068 PDB Ligand Immunopharmacology Ligand 11178 BIIB-068, compound 1 [PMID: 32696648]
bimekizumab Approved drug Immunopharmacology Ligand 9411 bimekizumab-bkzx, Bimzelx®, CA028_0496, CDP4940, gL7gH9, UCB-4940, UCB4940, Zu-G1
bimosiamose Immunopharmacology Ligand 9049 compound 15e [PMID: 9544210], TBC 1269, TBC-1269, TBC1269
bindarit Immunopharmacology Ligand 11124 AF-2838, AF2838
BIO-7488 Immunopharmacology Ligand 13341 BIO7488
BIO-8169 Immunopharmacology Ligand 13355 BIO8169, compound 2 [PMID: 38695469]
BIRT 377 Immunopharmacology Ligand 9720 BIRT-377
blinatumomab Approved drug Immunopharmacology Ligand 7384 Blincyto®, bscCD19xCD3, MEDI-538, MT-103, MT103
blisibimod Immunopharmacology Ligand 9518 A-623, AGP3 peptibody, AMG 623, Fc-Agp-3
BML-281 Immunopharmacology Ligand 9664 compound 3 [PMID: 18642892]
BMS-1001 Immunopharmacology Ligand 10191 BMS1001, Example 1001 [WO2015160641A2]
BMS-1166 Immunopharmacology Ligand 9608 compound 2c [PMID: 28613862], Example 1166 [WO2015160641A2]
BMS-202 PDB Ligand Immunopharmacology Ligand 9607 compound 1c [PMID: 28613862], PD1-PDL1 inhibitor 2
BMS-345541 Immunopharmacology Ligand 5669 BMS 345541, BMS345541
BMS-509744 Immunopharmacology Ligand 9994 BMS 509744, BMS509744, compound 3 [PMID:16682193]
BMS-561392 Immunopharmacology Ligand 6509 BMS 561392, BMS561392, DPC-333
BMS-582949 PDB Ligand Immunopharmacology Ligand 7838 BMS 582949, BMS582949, PS 540446, PS-540446, PS540446
BMS-681 PDB Ligand Immunopharmacology Ligand 9430 compound 13d [PMID: 25893046]
BMS-817399 PDB Ligand Immunopharmacology Ligand 9497 compound 29 [PMID: 25101488]
BMS-852927 PDB Ligand Immunopharmacology Ligand 14079 BMS852927, compound 15 [PMID: 27994765], XL-041, XL041
BMS-986142 PDB Ligand Immunopharmacology Ligand 9857 BMS986142, compound 14f [PMID: 27583770]
BMS-986166 Immunopharmacology Ligand 11493 BMS986166, compound 14a [PMID: 30785748]
BMS-986235 Immunopharmacology Ligand 11024 BMS986235, compound 13c [PMID: 32407089], LAR-1219, LAR1219
BMS-986238 Immunopharmacology Ligand 13877 BMS 986238, BMS986238
BMS-986260 PDB Ligand Immunopharmacology Ligand 10662 BMS986260, compound 10 [Velaparthi et al., 2020], Example 32' [WO2016140884A1]
BMS-986104 derivative 12 Immunopharmacology Ligand 11494 compound 12 [PMID: 33492963]
BMS-986104 derivative 24 Immunopharmacology Ligand 11495 compound 24 [PMID: 33492963]
bortezomib Approved drug PDB Ligand Immunopharmacology Ligand Antimalarial Ligand 6391 peptide boronate, PS-341, Velcade®
bosutinib Approved drug PDB Ligand Immunopharmacology Ligand 5710 Bosulif®, SK 606, SK-606, SKI 606
branebrutinib Immunopharmacology Ligand 9869 BMS-986195, BMS986195, Example 223 [US20160115126A1]
brazikumab Immunopharmacology Ligand 9293 AMG 139, AMG-139, MEDI2070
brensocatib Approved drug Immunopharmacology Ligand 9412 AZD7986, Brinsupri®, compound 30, INS 1007, INS1007
brentuximab vedotin Approved drug Immunopharmacology Ligand 6772 Adcetris®, anti-CD30 ADC SGN-35, SGN 35
brepocitinib PDB Ligand Immunopharmacology Ligand 10459 compound 23 [PMID: 30113844], PF-06700841, PF06700841
briakinumab Immunopharmacology Ligand 9213 ABT-874, J-695, J695, Ozespa
brimapitide Immunopharmacology Ligand 9101 AM-111, D-JNKI-1, XG-102
brimonidine (UK14304) Approved drug PDB Ligand Immunopharmacology Ligand 520 Alphagan®, Lumify®, Mirvaso®, UK14,304, UK14304
briquilimab Immunopharmacology Ligand 13450 AMG-191, AMG191, JSP-191, JSP191
BRL-15572 Immunopharmacology Ligand 10 BRL 15572, BRL-15,572, BRL15572
brodalumab Approved drug Immunopharmacology Ligand 7540 AMG-827, AMG827, Kyntheum®, Lumicef®, Siliq®
bromfenac Approved drug PDB Ligand Immunopharmacology Ligand 7131 AHR-10282B, Bromday®, Prolensa®, Xibrom®
BsAb (CD89-CD20) Immunopharmacology Ligand 9833
BT7480 Immunopharmacology Ligand 12060 BCY11863, BT-7480
BTP2 Immunopharmacology Ligand 2438 YM-58483
budesonide Approved drug Immunopharmacology Ligand 7434 Entocort®, Eohilia® (budesonide oral suspension), Jorveza®, Pulmicort®, S-1320, Uceris®
butyric acid PDB Ligand Immunopharmacology Ligand 1059 butanoic acid, butyrate, C4
BX 471 Immunopharmacology Ligand 767 BX-471, BX-741
BX-795 PDB Ligand Immunopharmacology Ligand 8006 BX 795, BX795
 
C Back to top
C108297 Immunopharmacology Ligand 9180 Compound 52 [PMID:18226897]
C1-27 PDB Ligand Immunopharmacology Ligand 10719 GSTO1-IN-1
C-176 Immunopharmacology Ligand 13136 C-176 STING inhibitor
C391 Immunopharmacology Ligand 9570 compound 5 [PMID: 27994760]
C646 Immunopharmacology Ligand 7004
C5a Immunopharmacology Ligand 573 C5a anaphylatoxin, complement component C5a, human complement protein
cabiralizumab Immunopharmacology Ligand 9107 BMS-986227, FPA-008, FPA008
cadonilimab Approved drug Immunopharmacology Ligand 12966 AK-104, AK104
cambritaxestat PDB Ligand Immunopharmacology Ligand 13506 compound 9v [PMID: 27780639], CRT-0273750, CRT0273750, IOA-289
camoteskimab Immunopharmacology Ligand 13187 AEVI 007, AEVI-007, AVTX 007, AVTX-007, CERC 007, CERC-007, MEDI 2338
camrelizumab Approved drug Immunopharmacology Ligand 9758 INCSHR1210, SHR-1210
canakinumab Approved drug Immunopharmacology Ligand 6773 ACZ 885, ACZ885, Ilaris®
canertinib Immunopharmacology Ligand 5675 CI 1033, CI-1033, PD 183805 dihydrochloride
carotegrast Immunopharmacology Ligand 10511 HCA2969
carotegrast methyl Approved drug Immunopharmacology Ligand 10510 AJM-300, AJM300, Carogra®
carprofen Approved drug Immunopharmacology Ligand 7141 Ro-205720000
CBS-3595 Immunopharmacology Ligand 9610
CC-885 Immunopharmacology Ligand 9224
CCL1 Immunopharmacology Ligand 4404
CCL1 Immunopharmacology Ligand 812 I309, TCA-3
CCL11 Immunopharmacology Ligand 769 eotaxin
CCL11 Immunopharmacology Ligand 787 murine eotaxin
CCL11 Immunopharmacology Ligand 4416
CCL12 Immunopharmacology Ligand 4435
CCL13 Immunopharmacology Ligand 770 monocyte chemotactic protein-4
CCL14 Immunopharmacology Ligand 753 CCL14a, CKβ1, haemofiltrate CC chemokine 1 (HCC-1), HCC-1(1-74)
CCL15 Immunopharmacology Ligand 754 Lkn-1 [Leukotactin-1], macrophage inflammatory protein-1δ, MIP-1δ
CCL16 Immunopharmacology Ligand 1272
CCL17 Immunopharmacology Ligand 797 TARC, thymus- and activation-regulated chemokine
CCL18 Immunopharmacology Ligand 4382 macrophage inflammatory protein 4, small-inducible cytokine A18
CCL19 Immunopharmacology Ligand 810 β-chemokine exodus-3, ck β-11, ckβ11, MIP-3β
CCL19 Immunopharmacology Ligand 4417
CCL2 Immunopharmacology Ligand 771
CCL2 Immunopharmacology Ligand 4407
CCL2 Immunopharmacology Ligand 4406
CCL20 Immunopharmacology Ligand 4419
CCL20 Immunopharmacology Ligand 808 LARC, liver and activation-regulated chemokine, macrophage inflammatory protein-3α, MIP-3α
CCL20 Immunopharmacology Ligand 4418
CCL21 Immunopharmacology Ligand 811 ckβ9, TCA-4
CCL22 Immunopharmacology Ligand 4420
CCL22 Immunopharmacology Ligand 798 dc/β-ck, macrophage-derived chemokine, STCP1
CCL23 Immunopharmacology Ligand 755 ckβ8-1, myeloid progenitor inhibitor factor-1
CCL24 Immunopharmacology Ligand 4421
CCL24 Immunopharmacology Ligand 775 eotaxin-2
CCL25 Immunopharmacology Ligand 817
CCL25 Immunopharmacology Ligand 4422
CCL26 Immunopharmacology Ligand 776 MIP-4α, PTEC
CCL27 Immunopharmacology Ligand 3646
CCL27 Immunopharmacology Ligand 4462
CCL28 Immunopharmacology Ligand 4463
CCL28 Immunopharmacology Ligand 3649
CCL3 Immunopharmacology Ligand 4409
CCL3 Immunopharmacology Ligand 4408
CCL3 Immunopharmacology Ligand 756 macrophage inflammatory protein-1α, MIP-1α
CCL4 Immunopharmacology Ligand 757 HC21, macrophage inflammatory protein-1β, MIP-1β
CCL4 Immunopharmacology Ligand 4411
CCL4 Immunopharmacology Ligand 4410
CCL5 Immunopharmacology Ligand 4412
CCL5 Immunopharmacology Ligand 758 eosinophil chemotactic cytokine [EoCP], regulated upon activation normal T cell expressed and secreted (RANTES)
CCL7 Immunopharmacology Ligand 4414
CCL7 Immunopharmacology Ligand 759
CCL7 Immunopharmacology Ligand 4413
CCL8 Immunopharmacology Ligand 772 monocyte chemotactic protein-2
CCL8 Immunopharmacology Ligand 4415
CCL9 Immunopharmacology Ligand 4434
Ccl21a Immunopharmacology Ligand 8651 6Ckine-Ser, Exodus-2
Ccl21b Immunopharmacology Ligand 8652 6Ckine-Leu, Exodus-2
CCR2-RA-[R] PDB Ligand Immunopharmacology Ligand 9431 analog 49 (Dasse et al., 2007)
CCX354 Immunopharmacology Ligand 10164 CCX 354, CCX-354, CCX-354-C
CD40 ligand Immunopharmacology Ligand 5077 CD40 ligand, membrane form
CDP840 Immunopharmacology Ligand 9330 CDP 840, CDP-840
CEE321 Immunopharmacology Ligand 12350 CEE-321, compound 1e [PMID: 36657024]
celastrol PDB Ligand Immunopharmacology Ligand 10386 compound 2 [PMID: 28621943]
celecoxib Approved drug PDB Ligand Immunopharmacology Ligand 2892 Celecox®, Elyxyb® (DFN-15; oral solution), Onsenal®, SC-58635, SC58635
cemiplimab Approved drug Immunopharmacology Ligand 10090 cemiplimab-rwlc, Libtayo®, REGN-2810, REGN2810, SAR-439684, SAR439684
cenerimod PDB Ligand Immunopharmacology Ligand 9824 ACT-334441
cenicriviroc Immunopharmacology Ligand 801 TAK 652, TAK-652, TAK652, TBR-652
cerdulatinib PDB Ligand Immunopharmacology Ligand 8957 PRT 062070, PRT-062070, PRT-2070, PRT062070
certolizumab pegol Approved drug Immunopharmacology Ligand 6774 CDP870, Cimzia®, PHA 738144
cetirizine Approved drug Immunopharmacology Ligand 1222 Reactine®, Zyrtec®
cetrorelix Approved drug Immunopharmacology Ligand 1190 Cetrotide®, SB-075
CG200745 Immunopharmacology Ligand 10055 CG-2, CG-200745, HDCG-0745
2'3'-cGAMP PDB Ligand Immunopharmacology Ligand 9207 cyclic [G(2',5')pA(3',5')p], cyclic GMP-AMP, Cyclic guanosine monophosphate-adenosine monophosphate
CGI1746 PDB Ligand Immunopharmacology Ligand 8066 CGI 1746, CGI-1746
CGI560 Immunopharmacology Ligand 9264 CGI-560
CH-4051 Immunopharmacology Ligand 9844 Formula (10) [WO2012078708A1]
chloroquine Approved drug PDB Ligand Immunopharmacology Ligand Antimalarial Ligand 5535 Aralen®, chloraquine, Malaquin®
CHMFL-BTK-11 Immunopharmacology Ligand 9516
cibinetide Immunopharmacology Ligand 9677 ARA 290, ARA-290, PH-BSP, PHBSP
cicaprost Immunopharmacology Ligand 1917 ZK 96480, ZK-96480
ciclesonide Approved drug Immunopharmacology Ligand 7469 Alvesco®, Omnaris®, RPR-251526
ciforadenant Immunopharmacology Ligand 10190 CPI-444, CPI444, V-81444, V81444
cilomilast PDB Ligand Immunopharmacology Ligand 7407 SB-207499
cintirorgon Immunopharmacology Ligand 10045 compound 32J [WO2016201225A1], LYC-55716, LYC55716
cipemastat Immunopharmacology Ligand 6466 Ro 28-2653
civorebrutinib Immunopharmacology Ligand 12868
clazakizumab Immunopharmacology Ligand 9195 ALD-518, ALD518, BMS-945429
clemastine Approved drug Immunopharmacology Ligand 6063 HS-592, meclastin, Tavegil®, Tavist®
clemizole PDB Ligand Immunopharmacology Ligand 10285
clobenpropit PDB Ligand Immunopharmacology Ligand 1223 VUF 9153, VUF-9153
clobetasol propionate Approved drug PDB Ligand Immunopharmacology Ligand 7062 CCI-4725, Clobex®, Dermovate®, GR 2/925, Temovate®
clobetasone Approved drug Immunopharmacology Ligand 9088 Eumovate®
clodronic acid Approved drug Immunopharmacology Ligand 9605 Bonefos®, Clasteon ®, clodronate, Loron®
clofazimine Approved drug Immunopharmacology Ligand 9184 Lamprene®
clopidogrel (active metabolite) Immunopharmacology Ligand 1772
CNX-774 Immunopharmacology Ligand 9266
colchicine Approved drug PDB Ligand Immunopharmacology Ligand 2367 Colcrys®, methoxylated analogue of XD1, XD25
complement C3 Immunopharmacology Ligand 9414
complement C5 Immunopharmacology Ligand 8712
compound 48/80 PDB Ligand Immunopharmacology Ligand 5531
compound 3a [Pipionne et al, 2018] Immunopharmacology Ligand 9965
compound 10a [PMID: 31283223] Immunopharmacology Ligand 10435
compound 12a [PMID: 29031075] Immunopharmacology Ligand 9684
compound 19a [PMID: 26506089] Immunopharmacology Ligand 9842
compound 8a [PMID: 23713581] Immunopharmacology Ligand 8856
compound 21b [PMID: 31136173] Immunopharmacology Ligand 10403
compound 5b [PMID: 29457898] Immunopharmacology Ligand 9835
compound 5b [PMID: 31287314] Immunopharmacology Ligand 10434
compound 18c [PMID: 25901531] Immunopharmacology Ligand 9227
compound 3c [PMID: 30360354] Immunopharmacology Ligand 10591 [As(4-F)F4]-GHRP-6, azasulfuryl-p-fluorophenylalanine-4-[As(4-F)F4]-GHRP-6, H-His-D-Trp-Ala-(4-F)AsF-D-Phe-Lys-NH2
compound 7c [PMID: 22041175] Immunopharmacology Ligand 9931
compound 8c [PMID: 28760529] Immunopharmacology Ligand 9671
Compound 9 [doi:10.26434/chemrxiv.7072592.v1] Immunopharmacology Ligand 10083
compound 17d [PMID: 23099093] Immunopharmacology Ligand 8196
compound 5d [PMID: 31335136] Immunopharmacology Ligand 10441 Example 59 [WO2018121550]
compound 7d [PMID: 29672049] Immunopharmacology Ligand 9937
compound 18e [PMID: 31670517] PDB Ligand Immunopharmacology Ligand 10549
compound 4e [PMID: 35546685] Immunopharmacology Ligand 12122 CHF-6297, CHF6297, CHI 91040, CHI91040, p38α MAPK-IN-5
compound 5e [PMID: 28580438] Immunopharmacology Ligand 9712
compound 14f [PMID: 35063894] Immunopharmacology Ligand 11936
compound 20f [PMID: 28520415] Immunopharmacology Ligand 9961
compound 7f [PMID: 29191554] PDB Ligand Immunopharmacology Ligand 9794 example 32 [WO2011078413]
compound 7f [PMID: 29283260] Immunopharmacology Ligand 9780
compound 2g [PMID: 27390066] Immunopharmacology Ligand 9682
compound 4g [PMID: 2680437] Immunopharmacology Ligand 9198
compound G1 [PMID: 36689364] Immunopharmacology Ligand 12354
compound 8ic [PMID: 19081254] Immunopharmacology Ligand 9478 CCR4 Antagonist
compound III [PMID: 24045148] Immunopharmacology Ligand 9709
compound II [PMID: 21329883] Immunopharmacology Ligand 9579
compound 16i [PMID: 31525963] Immunopharmacology Ligand 10502
compound 5i [PMID: 36542759] Immunopharmacology Ligand 12336
compound 9 [Kumar et al., 2019] Immunopharmacology Ligand 10448
compound 17l [PMID: 26288691] Immunopharmacology Ligand 10035
compound 29 [Moslin et al., 2017] Immunopharmacology Ligand 9992
compound 12p [Larson et al., 2017] Immunopharmacology Ligand 9690
compound 10 [PMID: 31411465] Immunopharmacology Ligand 10488 example 8 (cis racemate) [WO2017060855A1]
compound 11 [PMID: 29442501] Immunopharmacology Ligand 9819
compound 12 [PMID: 27448772] PDB Ligand Immunopharmacology Ligand 9453
compound 15 [PMID: 25411721] Immunopharmacology Ligand 9078 example 252 [WO2007110237]
compound 15 [PMID: 32045236] Immunopharmacology Ligand 10706
compound 16 [PMID: 26794040] Immunopharmacology Ligand 9223
compound 16 [PMID: 31525966] Immunopharmacology Ligand 10501
compound 17 [PMID: 29741897] Immunopharmacology Ligand 10005
compound 182 [PMID: 37500611] PDB Ligand Immunopharmacology Ligand 13005 compound XI [PMID: 37500611]
compound 1 [PMID: 24930776] Immunopharmacology Ligand 9092 DB36
compound 1 [PMID: 28611375] Immunopharmacology Ligand 9673
compound 1 [PMID: 31477924] Immunopharmacology Ligand 10481
compound 21 [PMID: 22802221] Immunopharmacology Ligand 6918 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt, C21
compound 21 [PMID: 24900635] Immunopharmacology Ligand 8187
compound 24 [PMID: 26987013 ] Immunopharmacology Ligand 9252
compound 25 [PMID: 28038940] Immunopharmacology Ligand 9700
compound 25 [PMID: 31260299] Immunopharmacology Ligand 10428
compound 25 [PMID: 32105470] Immunopharmacology Ligand 10718
compound 25 [PMID: 32687365] Immunopharmacology Ligand 11130
compound 26 [PMID: 31710475] Immunopharmacology Ligand 10602
compound 27 [PMID: 24900635] Immunopharmacology Ligand 10133
compound 28 [PMID: 28671460] Immunopharmacology Ligand 9670
compound 29 [PMID: 31934767] Immunopharmacology Ligand 10596
compound 2 [PMID: 28621538] PDB Ligand Immunopharmacology Ligand 11282 example 727 [WO2012093101A1]
compound 31 [PMID: 31259550] Immunopharmacology Ligand 10417
compound 32 [PMID: 31638797] Immunopharmacology Ligand 10528 example 69 [WO2016179460A1]
compound 32 [PMID: 38047891] Immunopharmacology Ligand 13050
compound 36 [PMID: 21958547] Immunopharmacology Ligand 9391
compound 37 [PMID: 29193967] Immunopharmacology Ligand 9797
compound 39 [PMID: 31742400] Immunopharmacology Ligand 10585
compound 3 [PMID: 28603634] Immunopharmacology Ligand 9628
compound 3 [PMID: 29633584] Immunopharmacology Ligand 9960
compound 41 [PMID: 25000588] Immunopharmacology Ligand 9349
compound 41 [PMID: 31855425] PDB Ligand Immunopharmacology Ligand 10598
compound 43 [PMID: 26751273] Immunopharmacology Ligand 9492
compound 47 [PMID: 28737909] Immunopharmacology Ligand 9646
compound 49 [PMID: 36529947] Immunopharmacology Ligand 12355
compound 52 [PMID: 28541707] Immunopharmacology Ligand 10001
compound 52 [PMID: 32902255] Immunopharmacology Ligand 13913 IL-4 inhibitor 4
compound 76 [PMID: 28657314] Immunopharmacology Ligand 9609
compound 7 [PMID: 31381331] Immunopharmacology Ligand 10450
compound 8 [PMID: 25898023] Immunopharmacology Ligand 10498
compound 9 [PMID: 26006010] Immunopharmacology Ligand 9761
compound (S)-29 [PMID: 37606563] Immunopharmacology Ligand 12904
compound 2q [PMID: 30986068] PDB Ligand Immunopharmacology Ligand 10365 example 2-8 [US20150353552]
compound 14 [Schnute et al., 2023] Immunopharmacology Ligand 12351
compound T.14 Immunopharmacology Ligand 10385
compound 8u [PMID: 31999451] Immunopharmacology Ligand 10682
compound 3v [PMID: 27390066] Immunopharmacology Ligand 9683
compound 1 [WO2012007375] Immunopharmacology Ligand 8084
compound 7 [WO2012007375] Immunopharmacology Ligand 8085
compound 669 [WO2021055376A1] Immunopharmacology Ligand 13911
compound 71 [WO2018191577A1] Immunopharmacology Ligand 11203
compound XVI [PMID: 38863440] Immunopharmacology Ligand 13423
compound 25 [Zhang et al., 2020] PDB Ligand Immunopharmacology Ligand 10643 example 6B [WO2014028600A2]
compound 15z [PMID: 38029358] Immunopharmacology Ligand 13044 NLRP3 inhibitor 15z
compstatin Immunopharmacology Ligand 9218
CORM-2 Immunopharmacology Ligand 9535
corticosterone PDB Ligand Immunopharmacology Ligand 2869
corticotropin zinc hydroxide Approved drug Immunopharmacology Ligand 6967
cortisol Approved drug PDB Ligand Immunopharmacology Ligand 2868 Acticort®, Efmody®, Plenadren®
COVA322 Immunopharmacology Ligand 10469
CP105696 Immunopharmacology Ligand 3368 CP 105696, CP-105,696, CP-105696
CP-195543 Immunopharmacology Ligand 6155 CP 195543, CP-195,543, CP195543
CP-412,245 Immunopharmacology Ligand 11809
CP-424,174 Immunopharmacology Ligand 11810 CP-424174
CpdA (parent molecule) Immunopharmacology Ligand 11317
CPUY192018 Immunopharmacology Ligand 9710 compound 18e [PMID: 26258437], compound 2 [PMID: 24512214]
CR6086 Immunopharmacology Ligand 9845
CRAC channel inhibitor 5b [PMID: 26256403] Immunopharmacology Ligand 10042
CRAC channel inhibitor 1 [PMID: 26256403] Immunopharmacology Ligand 10041
CRAMP Immunopharmacology Ligand 6266
crenolanib PDB Ligand Immunopharmacology Ligand 7882 ARO-002, CP 868596, CP-868,596, CP-868596
crisaborole Approved drug Immunopharmacology Ligand 9151 AN 2728, AN2728, compound 5b [PMID: 19303290], Eucrisa®, Staquis®
crizotinib Approved drug PDB Ligand Immunopharmacology Ligand 4903 (R)-crizotinib, PF 2341066, PF-02341066, PF-2341066, PF2341066, Xalkori®
cromoglicic acid Approved drug Immunopharmacology Ligand 7608 cromoglycate, cromolyn, cromolyn sodium, FPL-670, Intal®, Opticrom®, sodium cromoglicate
crovalimab Approved drug Immunopharmacology Ligand 12790 crovalimab-akkz, Piasky®, RG-6107, RG6107, Senkai® (China), SKY59
CRX-555 Immunopharmacology Ligand 10091 CRX555, N-[(3R)-3-(Octanoyloxy)myristoyl]-O-[2-[[(3R)-3-(octanoyloxy)myristoyl]amino]-3-O-[(3R)-3-(octanoyloxy)myristoyl]-4-O-phosphono-2-deoxy-beta-D-glucopyranosyl]-L-serine
CU-CPT8m PDB Ligand Immunopharmacology Ligand 9795 7-(m-Tolyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide, compound 5 [PMID: 29155428]
cusatuzumab Immunopharmacology Ligand 9778 ARGX-110, ARGX110, clone 41D12
CVN293 Immunopharmacology Ligand 13373 CVN-293
CX549 Immunopharmacology Ligand 9701 compound 63 [WO2016048861], CX-549
CXCL1 Immunopharmacology Ligand 4423
CXCL1 Immunopharmacology Ligand 826 CINC, GROα, macrophage inflammatory protein-2
CXCL1 Immunopharmacology Ligand 819 GROα, melanocyte growth-stimulatory activity, MIP-2
CXCL10 Immunopharmacology Ligand 835
CXCL10 Immunopharmacology Ligand 4430
CXCL10 Immunopharmacology Ligand 4431
CXCL11 Immunopharmacology Ligand 836 IP9, ITAC
CXCL11 Immunopharmacology Ligand 4432
CXCL12 Immunopharmacology Ligand 4465
CXCL12α Immunopharmacology Ligand 4358 CXCL12 α, SDF-1α, stromal cell-derived factor-1α
CXCL12β Immunopharmacology Ligand 845 SDF-1β, stromal cell-derived factor-1 (SDF-1), stromal cell-derived factor-1β
CXCL12δ Immunopharmacology Ligand 8531
CXCL12ε Immunopharmacology Ligand 8532
CXCL12γ Immunopharmacology Ligand 8530
CXCL12φ Immunopharmacology Ligand 8533
CXCL13 Immunopharmacology Ligand 4466
CXCL13 Immunopharmacology Ligand 3645 BCA-1
CXCL14 Immunopharmacology Ligand 3680 BMAC
CXCL15 Immunopharmacology Ligand 3862 lungkine (mouse)
CXCL16 Immunopharmacology Ligand 855
CXCL16 Immunopharmacology Ligand 4433
CXCL16 Immunopharmacology Ligand 4467
CXCL17 Immunopharmacology Ligand 6479 C-X-C motif chemokine 17, dendritic cell and monocyte chemokine-like protein
CXCL2 Immunopharmacology Ligand 4425
CXCL2 Immunopharmacology Ligand 827 GROβ, MIP-2α
CXCL2 Immunopharmacology Ligand 4424 macrophage inflammatory protein 2 (MIP-2)
CXCL3 Immunopharmacology Ligand 4427
CXCL3 Immunopharmacology Ligand 4426
CXCL3 Immunopharmacology Ligand 828 GROγ, MIP-2β
CXCL4 Immunopharmacology Ligand 3685 platelet factor 4 (PF4)
CXCL5 Immunopharmacology Ligand 4428
CXCL5 Immunopharmacology Ligand 829 ENA-78
CXCL5 Immunopharmacology Ligand 4464
CXCL6 Immunopharmacology Ligand 820
CXCL7 Immunopharmacology Ligand 830 PPBP
CXCL8 Immunopharmacology Ligand 821 interleukin-8
CXCL9 Immunopharmacology Ligand 837 MIG, monokine induced by gamma-interferon
CXCL9 Immunopharmacology Ligand 4429
CX3CL1 Immunopharmacology Ligand 4468
CX3CL1 Immunopharmacology Ligand 4469
CX3CL1 Immunopharmacology Ligand 856 fractalkine, neurotactin
CXCR4 antagonist 22 Immunopharmacology Ligand 10146
CY-09 Immunopharmacology Ligand 10057
cyclic di-GMP PDB Ligand Immunopharmacology Ligand 13137 Bis-(3'-5')-cyclic dimeric guanosine monophosphate, c-di-GMP, cGpGp, dyclic diguanylate monophosphate
cyclosporin A Approved drug Immunopharmacology Ligand 1024 ciclosporin, cyclosporine, cyclosporine A, Ikervis® (opthalmic solution), Neoral®, Sandimmun®, Verkazia® (opthalmic solution)
CZ415 Immunopharmacology Ligand 9837 compound 3 [PMID: 27563401], CZ-415
 
D Back to top
D4476 Immunopharmacology Ligand 5940 casein kinase I inhibitor, CK1 inhibitor, D 4476
daclizumab Approved drug Immunopharmacology Ligand 6880 L04AC01, RO-24-7375, Ro-247375, Zenapax®
dagrocorat Immunopharmacology Ligand 9650 PF-00251802
danirixin Immunopharmacology Ligand 8500 GSK-1325756B, GSK1325756, GSK1325756B
dapansutrile Immunopharmacology Ligand 10056 OLT-1177, OLT1177
dapirolizumab pegol Immunopharmacology Ligand 11123 CDP-7657, CDP7657, DZP
darapladib PDB Ligand Immunopharmacology Ligand 6696 SB 480848, SB-480848
daratumumab Approved drug Immunopharmacology Ligand 7395 3003-005, Darzalex®, HuMax-CD38, JNJ-54767414
dasatinib Approved drug PDB Ligand Immunopharmacology Ligand 5678 BMS 345825, BMS 354825, BMS 35482513, Sprycel®
dazodalibep Immunopharmacology Ligand 13453 MEDI-4920, MEDI4920, VIB 4920, VIB-4920, VIB4920
DDR1/2 inhibitor 5n PDB Ligand Immunopharmacology Ligand 10105
decernotinib PDB Ligand Immunopharmacology Ligand 8309 adelatinib, VRT-831509, VX-509
dectrekumab Immunopharmacology Ligand 8714 QAX-576, QAX576
deflazacort Approved drug Immunopharmacology Ligand 9477 Emflaza®, MDL 458
defoslimod Immunopharmacology Ligand 9024 OM 174, OM-174
delgocitinib Approved drug PDB Ligand Immunopharmacology Ligand 9619 Anzupgo®, Corectim®, ent-60, JTE-052, JTE052
denileukin diftitox Approved drug Immunopharmacology Ligand 7044 DAB389 IL2, denileukin diftitox-cxdl, LY 335348, Lymphir®, Ontak®
14-Deoxy-11,12-didehydroandrographolide Immunopharmacology Ligand 13464 ddA (14-deoxy-11,12-didehydroandrographolide)
desloratadine Approved drug PDB Ligand Immunopharmacology Ligand 7157 Clarinex®, SCH-34117
desonide Approved drug Immunopharmacology Ligand 7066 D-2083, Desowen®
desoximetasone Approved drug Immunopharmacology Ligand 7067 A-41-304, HOE-304, R-2113, Topicort®
deucravacitinib Approved drug Immunopharmacology Ligand 10432 BMS-986165, BMS986165, compound 11 [PMID: 31318208}, Sotyktu®, Tyk2-IN-4
deuruxolitinib Approved drug Immunopharmacology Ligand 11410 CTP-543, CTP543, D8-ruxolitinib, Leqselvi®
dexamethasone Approved drug PDB Ligand Immunopharmacology Ligand 2768 Decadron®, desametasone, fluormethylprednisolone
dezapelisib Immunopharmacology Ligand 9728 compound 67 [PMID: 22924688], example 15 [WO2011008487], INCB 40093, INCB40093
(R)-DFV890 PDB Ligand Immunopharmacology Ligand 13782 compound (R)-1 [PMID: 40036600], DFV-890, IFM-2427, IFM2427
diamorphine Immunopharmacology Ligand 9082 acetomorphine, diacetylmorphine, heroin
diclofenac Approved drug PDB Ligand Immunopharmacology Ligand 2714 Cataflam®, CGP-45840B, GP-45840, Voltaren®, Voltarol®
difamilast Approved drug Immunopharmacology Ligand 9776 example 352 [WO2007058338], MM36, Moizerto®, OPA-15406
difelikefalin Approved drug Immunopharmacology Ligand 9044 CR845, D-Phe-D-Phe-D-Leu-D-Lys-[γ-(4-N-piperidinyl)amino carboxylic acid], FE-202845, Kapruvia®, Korsuva®, SEQ ID NO: 2
diflapolin Immunopharmacology Ligand 10080
diflorasone diacetate Approved drug Immunopharmacology Ligand 7068 Psorcon®, U-34865
diflunisal Approved drug PDB Ligand Immunopharmacology Ligand 7162 Dolobid®
difluprednate Approved drug Immunopharmacology Ligand 7474 DFBA, Durezol®, W-6309
dilmapimod Immunopharmacology Ligand 7815 SB-681323
dimethyl fumarate Approved drug PDB Ligand Immunopharmacology Ligand 7045 BG-12, BG00012, fumaric acid, Tecfidera®
dimethyl itaconate Immunopharmacology Ligand 9939 dimethylitaconate, itaconic acid dimethyl ester
dimetindene Approved drug Immunopharmacology Ligand 10101 (+/-)-dimethindene, dimethindene, dimethpyrindene, Fenistil®, Vibrocil®
(S)-dimetindene Immunopharmacology Ligand 10104 (+)-dimethindene, (+)-dimetindene, (S)-dimethindene
diminazene PDB Ligand Immunopharmacology Ligand 10307 Azidin®, Berenil®, Pirocide®
dinaciclib Immunopharmacology Ligand 7379 SCH727965
diphenylpyraline Approved drug Immunopharmacology Ligand 7165 Hispril®
diprovocim-1 PDB Ligand Immunopharmacology Ligand 10341 compound 3 [PMID: 30272974]
diroleuton PDB Ligand Immunopharmacology Ligand 9775 8,11,14-Eicosatrienoic acid, DGLA, dihomo-gamma-linolenic acid, DS107, Homo-gamma-linolenic acid
diroximel fumarate Approved drug Immunopharmacology Ligand 10525 ALKS-8700, ALKS8700, BIIB098, Vumerity®
divozilimab Approved drug Immunopharmacology Ligand 13087 BCD 132, BCD-132, Ivlizi®
DMAT PDB Ligand Immunopharmacology Ligand 9323 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole, CK2 Inhibitor II
DO264 Immunopharmacology Ligand 10250 compound 46, DO-264
domvanalimab Immunopharmacology Ligand 13983 AB-154, AB154
dopamine Approved drug PDB Ligand Immunopharmacology Ligand 940 3-hydroxytyramine
doramapimod PDB Ligand Immunopharmacology Ligand 5668 BIRB 796BS, BIRB-796, BIRB796
dordaviprone Approved drug Immunopharmacology Ligand 9978 Modeyso®, ONC-201, ONC201, TIC-10, TIC10
dostarlimab Approved drug Immunopharmacology Ligand 11518 ANB-011, dostarlimab-gxly, Jemperli®, TSR-042, WBP-285
doxycycline Approved drug PDB Ligand Immunopharmacology Ligand Antimalarial Ligand 6464 BMY-28689, Monodox®, Vibramycin®
dual sEH/FAAH inhibitor 11 Immunopharmacology Ligand 10124 compound B-11 [WO2017160861], example 28 [WO2017160861]
dubermatinib Immunopharmacology Ligand 8863 compound 13, TP 0903, TP-0903, TP0903
dupilumab Approved drug Immunopharmacology Ligand 7574 Dupixent®, REGN668, SAR231893
durvalumab Approved drug Immunopharmacology Ligand 7985 anti-B7H1 monoclonal antibody, Imfinzi®, MEDI-4736, MEDI4736
duvelisib Approved drug Immunopharmacology Ligand 7795 compound 4904 [Patent US8193182], Copiktra®, INK-1197, IPI-145
DX-2507 Immunopharmacology Ligand 9959
dyphylline Approved drug Immunopharmacology Ligand 7070 Dilor®
 
E Back to top
6E11 Immunopharmacology Ligand 9749
E-52862 PDB Ligand Immunopharmacology Ligand 10431 compound 28 [PMID: 22784008], E52862, MR309, sigma 1 receptor antagonist (S1RA)
E6201 PDB Ligand Immunopharmacology Ligand 7836 E 6201, E-6201
ebdarokimab Approved drug Immunopharmacology Ligand 13875 AK-101, AK101
ecallantide Approved drug Immunopharmacology Ligand 6955 DX-88, FOV2302, Kalbitor®
eclitasertib Immunopharmacology Ligand 11308 DNL-758, DNL758, example 42 [WO2017136727A2], SAR443122
eculizumab Approved drug Immunopharmacology Ligand 6884 h5G1.1, h5G1.1VHC, Soliris®
edicotinib Immunopharmacology Ligand 8942 JNJ-40346527, JNJ40346527, US8497376, 15
efalizumab Approved drug Immunopharmacology Ligand 6593 anti alphaL integrin, antiCD11 alpha, hu1124, Raptiva®
efgartigimod alfa Approved drug Immunopharmacology Ligand 9777 ARGX-113, efgartigimod alfa-fcab, Vyvgart®
efineptakin alfa Immunopharmacology Ligand 11097 GX-I7, Hyleukin-7, Il-7 hybrid Fc, NT-I7, rhIL-7-hyFc, TJ-107
efzofitimod Immunopharmacology Ligand 13199 ATYR-1923, ATYR1923, KRP-R120
EG01377 PDB Ligand Immunopharmacology Ligand 9904 (3-((5-(4-(aminomethyl)phenyl)-2,3-dihydrobenzofuran)-7-sulfonamido)thiophene- 2-carbonyl)-L-arginine, compound 1 [PMID: 29648813]
eganelisib PDB Ligand Immunopharmacology Ligand 9563 compound 26 [PMID: 27660692], IPI-549, IPI549
elafin Immunopharmacology Ligand 12035 cementoin, trappin-2
eldelumab Immunopharmacology Ligand 9047 BMS-936557, MDX-1100
elenestinib Immunopharmacology Ligand 12357 BLU-263, BLU263, exampl4 4 [WO2020210293A1]
elezanumab Immunopharmacology Ligand 9290 ABT-555, AE12-1Y-QL
elotuzumab Approved drug Immunopharmacology Ligand 8361 BMS-901608, Empliciti®, HuLuc63
elranatamab Approved drug Immunopharmacology Ligand 12889 elranatamab-bcmm, Elrexfio®, PF-06863135, PF06863135
elsubrutinib Immunopharmacology Ligand 10464 example #30 (S) [WO2014210255A1]
elubirixin Immunopharmacology Ligand 8499 SB 656933, SB-656933, SB656933
emactuzumab Immunopharmacology Ligand 8944 RG7155, RO5509554
emapalumab Approved drug Immunopharmacology Ligand 9295 emapalumab-lzsg, Gamifant®, NI-0501, NI0501
emavusertib PDB Ligand Immunopharmacology Ligand 10152 AU-4948, AU4948, CA4948, compound 24 [PMID: 33335659]
emlenoflast Immunopharmacology Ligand 12172 Inzomelid, MCC-7840, MCC7840
enexasogaol Immunopharmacology Ligand 9773 6-Shogaol, [6]-shogaol, trans-6-shogaol
enoblituzumab Immunopharmacology Ligand 9589 MGA-271, MGA271
enokizumab Immunopharmacology Ligand 8934 7F3com-2H2, MEDI-528, MEDI528
enpatoran PDB Ligand Immunopharmacology Ligand 11307 compound 73 [WO2017106607A1], M-5049, M5049
ENPP1 inhibitor 27 Immunopharmacology Ligand 13937
ensifentrine Approved drug Immunopharmacology Ligand 11865 Ohtuvayre®, RPL554, VMX 554, VMX-554, VMX554
envafolimab Approved drug Immunopharmacology Ligand 10492 Envida®, KN-035, KN035
epacadostat PDB Ligand Immunopharmacology Ligand 8221 IDO inhibitor 1, INCB 24360, INCB-24360, INCB024360
epcoritamab Approved drug Immunopharmacology Ligand 11442 epcoritamab-bysp, Epkinly®, GEN-3013, GEN3013, Tepkinly®
epinastine Approved drug Immunopharmacology Ligand 7176 Elestat®, epinastine hydrochloride
epratuzumab Immunopharmacology Ligand 8088 90Y-DOTA-hLL2, 90Y-epratuzumab tetraxetan, 90Y-hLL2, AMG-412, IMMU-hLL2, LymphoCide® (proposed proprietary name)
ER-27319 Immunopharmacology Ligand 9611
esflurbiprofen Approved drug PDB Ligand Immunopharmacology Ligand 9420 (S)-flurbiprofen, BTS-24332, SFPP, TT-063
etanercept Approved drug Immunopharmacology Ligand 6789 Enbrel®, Rhu Tnfr:Fc, TNFR-Fc, TNR 001
etigilimab Immunopharmacology Ligand 13984 OMP-313M32
etodolac Approved drug Immunopharmacology Ligand 7185 AY-24236, Lodine®
etoricoxib Approved drug PDB Ligand Immunopharmacology Ligand 2896 Arcoxia®, MK 0663, MK-0663, MK0663
etrasimod Approved drug Immunopharmacology Ligand 9331 APD-334, APD334, APD334-003, compound 4 [PMID: 25516790], Velsipity®
etrolizumab Immunopharmacology Ligand 8407 PRO145223, RG-7413, RG7413, rhuMAb Beta7
everolimus Approved drug Immunopharmacology Ligand 5889 Afinitor®, Certican®, RAD-001, RAD001, rapamycin, 42-O-(2-hydroxyethyl)-, Zortress®
evobrutinib PDB Ligand Immunopharmacology Ligand 9752 A250 [WO2012170976], M-2951, M2951, MSC 2364447, MSC-2364447C, MSC2364447C
example 131 [WO2009133348] Immunopharmacology Ligand 8489
example 25 [WO2018228934] Immunopharmacology Ligand 10201
example 36 [WO2016177845] Immunopharmacology Ligand 9555
Example 4 [WO2017202275A1] Immunopharmacology Ligand 10449
 
F Back to top
F16357 Immunopharmacology Ligand 9255 Compound 39 [PMID: 19791800], Example 1 in WO2007147824
F215 Immunopharmacology Ligand 10121
Fas ligand Immunopharmacology Ligand 5078 apoptosis antigen ligand, CD95L
felzartamab Immunopharmacology Ligand 13455 MOR-03087, MOR-202, MOR03087, MOR202
fenebrutinib PDB Ligand Immunopharmacology Ligand 9299 Example 130 [US20140194408], GDC-0853, GDC0853, RG-7845, RG7845
fenoprofen Approved drug Immunopharmacology Ligand 4820 fenoprofen calcium, Nalfon®
fevipiprant PDB Ligand Immunopharmacology Ligand 8995 NVP-QAW039, QAW039
fexofenadine Approved drug Immunopharmacology Ligand 4819 Allegra®, fexofenadine HCl
fezakinumab Immunopharmacology Ligand 9281 ILV-094
filgotinib Approved drug PDB Ligand Immunopharmacology Ligand 7913 GLPG-0634, GLPG0634, Jyseleca®
filgrastim Approved drug Immunopharmacology Ligand 6968 Filcad®, Imumax ®, R-METHUG-CSF
fimepinostat Immunopharmacology Ligand 8952 CUDC 907, CUDC-907, PI3K/HDAC Inhibitor centn
fingolimod Approved drug Immunopharmacology Ligand 2407 FTY-720, FTY720, Gilenya®
FIPI Immunopharmacology Ligand 8781 compound 14 [PMID: 19136975]
firategrast Immunopharmacology Ligand 11486 SB-683699, SB683699
fludroxycortide Approved drug Immunopharmacology Ligand 7606 Cordran®, flurandrenolide, flurandrenolone, Haelan®
flufenamic acid Approved drug PDB Ligand Immunopharmacology Ligand 2447
flumethasone pivalate Approved drug Immunopharmacology Ligand 7075 Locorten®
flunisolide Approved drug Immunopharmacology Ligand 7076 AeroBid®, RS-3999
fluocinolone acetonide Approved drug Immunopharmacology Ligand 7077 Capex®, Iluvien®, Synalar®
fluocinonide Approved drug Immunopharmacology Ligand 7078 Fluonex®, Lidex®
fluorescent MIF ligand B Ligand is labelled Immunopharmacology Ligand 9987
fluorometholone Approved drug Immunopharmacology Ligand 7079 Flarex®, FML®
flurbiprofen Approved drug Immunopharmacology Ligand 4194 Ansaid®, Froben®
fluticasone Approved drug Immunopharmacology Ligand 6699 Advair®, Avamys®, Flovent HFA®, Veramyst®
fluticasone furoate Approved drug PDB Ligand Immunopharmacology Ligand 10892 Arnuity Ellipta, Avamys, FF, Flonase Sensimist, Veramyst
fluticasone propionate Approved drug Immunopharmacology Ligand 7080 Advair Diskus®, ArmonAir RespiClickTM, CCI-18781, Flovent®
fluvoxamine Approved drug PDB Ligand Immunopharmacology Ligand 7189 Luvox®, U-23000
FLX475 Immunopharmacology Ligand 12153 example 43 [WO2018022992A1], FLX-475
fontolizumab Immunopharmacology Ligand 9847 HuZAF
formoterol Approved drug Immunopharmacology Ligand 3465 BD-40A, CGP-25827A, Foradil®, Oxeze/Oxis®, YM-08316
forsythoside B Immunopharmacology Ligand 10303
fosdagrocorat Immunopharmacology Ligand 9649 PF-04171327
fosifidancitinib Immunopharmacology Ligand 10637
fosizensertib Immunopharmacology Ligand 13806 compound 19 [WO2023018643A1]
fostamatinib Approved drug PDB Ligand Immunopharmacology Ligand 7796 R 788, R-788, R7935788, Tavalisse®, Tavlesse®
FR122047 Immunopharmacology Ligand 5191 FR 122047, FR 122047 hydrochloride, FR-122047
friluglanstat Immunopharmacology Ligand 12888 example 11 [US9216968B2]
 
G Back to top
gabapentin Approved drug PDB Ligand Immunopharmacology Ligand 5483 CI 945, Go 3450, GOE 2450, GOE 3450, Neurontin®
Galapagos MAPKAPK5 inhibitor D Immunopharmacology Ligand 9848 compound 183 [WO2007138072A2]
galcanezumab Approved drug Immunopharmacology Ligand 8967 clone III, Emgality®, galcanezumab-gnlm, LY-2951742, LY2951742
galectin-1 Immunopharmacology Ligand 6603 GBP
galectin-3 Immunopharmacology Ligand 6619 galectin 3, GALIG, LGALS2, MAC-2
galectin 9 Immunopharmacology Ligand 9594 Ecalectin, Gal-9, Tumor antigen HOM-HD-21
galectin-3 binding protein Immunopharmacology Ligand 6615 L3 antigen, Mac-2-binding protein, MAC-2-BP
gamcemetinib Immunopharmacology Ligand 12167 CC-99677, CC99677
gandotinib PDB Ligand Immunopharmacology Ligand 7909 LY-2784544, LY2784544
GB88 Immunopharmacology Ligand 6658 GB 88, GB-88
G-CSF Approved drug Immunopharmacology Ligand 4934 Granocyte®
GDC-0214 Immunopharmacology Ligand 12318 GDC0214, iJak-381, RG-6151, RG6151
GDC-0834 PDB Ligand Immunopharmacology Ligand 9263 GDC 0834
GDC-2394 PDB Ligand Immunopharmacology Ligand 12280 compound 20 [PMID: 36279149], GDC2394
gefapixant Approved drug PDB Ligand Immunopharmacology Ligand 9540 AF-219, AF219, Lyfnua®, MK7264, MK‐7264
gemtuzumab ozogamicin Approved drug Immunopharmacology Ligand 6775 CDP 771, CMA 676, hP67.6-calicheamicin, Mylotarg®, WAY-CMA 676
gevokizumab Immunopharmacology Ligand 7394 XOMA 052, XOMA-052
gimsilumab Immunopharmacology Ligand 9624 MORAb-022
GlcC14C18 Immunopharmacology Ligand 9483 6-O-(2'(R,S)-tetradecyloctadecanoyl)-D-glucose
glibenclamide Approved drug PDB Ligand Immunopharmacology Ligand 2414 Amglidia®, Diabeta®, glyburide, Glynase®
GLP-2 analogue 10 Immunopharmacology Ligand 9896
GLPG0974 PDB Ligand Immunopharmacology Ligand 8417 compound 99 [PMID 25380412]
GLPG1205 Immunopharmacology Ligand 10171 compound 122 [WO2013092791A1], GLPG-1205
GLPG3970 Immunopharmacology Ligand 12157 compound 32 [PMID: 38552030], compound 88 [WO2019238424A1], GLPG-3970
glycopyrrolate Approved drug Immunopharmacology Ligand 7459 AHR-504, Qbrexza® (glycopyrronium cloth), Robinul®, Seebri Neohaler®, Tovanor Breezhaler®
GM-CSF Immunopharmacology Ligand 4942 colony-stimulating factor, CSF
GNE-3500 Immunopharmacology Ligand 9660
GNE-4997 PDB Ligand Immunopharmacology Ligand 9995 compound 28 [PMID: 25844760], GNE 4997, GNE4997
GNE684 PDB Ligand Immunopharmacology Ligand 13107 GNE-684
GNF362 Immunopharmacology Ligand 9548 example 71 [US20090306039]
golimumab Approved drug Immunopharmacology Ligand 6776 CNTO-148, CNTO148, Simponi®
GPR15L Immunopharmacology Ligand 10567 antimicrobial peptide-57, colon-derived SUSD2 binding factor
GR-389988 Immunopharmacology Ligand 10257 Ex. 3-15 [US9174986B2], GR389988, GZ389988, GZ389988A
Grp94 inhibitor 54 Immunopharmacology Ligand 10118
GSK065 PDB Ligand Immunopharmacology Ligand 10358 GSK3335065, inhibitor C1 [PMID: 28604669]
GSK143 Immunopharmacology Ligand 9388 compound 20 [PMID: 21903390]
GSK1482160 PDB Ligand Immunopharmacology Ligand 10504 compound 1b [PMID: 31525963], compound 31 [PMID: 20673717], GSK-1482160
GSK2245035 Immunopharmacology Ligand 9254 compound 32 [PMID: 26861551]
GSK2256294 Immunopharmacology Ligand 9718 GSK-2256294, GSK-2256294A, GSK2256294A
GSK2292767 PDB Ligand Immunopharmacology Ligand 10633 compound 2 [PMID: 30532965], compound 3 [PMID: 26301626], GSK-2292767
GSK2646264 PDB Ligand Immunopharmacology Ligand 10108 compound 44 [PMID: 30249354]
GSK2879552 Immunopharmacology Ligand 9116 Example 26 [WO2012135113], GSK-2879552
GSK2981278 Immunopharmacology Ligand 9661
GSK2982772 PDB Ligand Immunopharmacology Ligand 9554 compound 5 [PMID: 28151659]
GSK3050002 Immunopharmacology Ligand 9623 E6071, KANAb071
GSK343 PDB Ligand Immunopharmacology Ligand 8240 compound 6 [PMID 24900432], GSK 343
GSK'547 Immunopharmacology Ligand 11274 example 6 [WO2020044206A1], GSK-547, GSK547
GSK583 PDB Ligand Immunopharmacology Ligand 9134 GSK'583
GSK8612 Immunopharmacology Ligand 10343
GSK866 PDB Ligand Immunopharmacology Ligand 9653
GSK963 Immunopharmacology Ligand 10132 GSK'963, GSK′963A
GSK2239633A Immunopharmacology Ligand 10416 compound 6 [PMID: 23409871], GSK-2239633A
GSK-7975A Immunopharmacology Ligand 10088 example 36 [US20120053150A1], GSK7975A
GSK-J1 PDB Ligand Immunopharmacology Ligand 7027
GSK-J4 Immunopharmacology Ligand 8979 GSK J4, GSKJ4
gumokimab Immunopharmacology Ligand 13889 AK-111, AK111
gusacitinib Immunopharmacology Ligand 10000 ASN-002, ASN002, example 189 [WO2013028818A1]
guselkumab Approved drug Immunopharmacology Ligand 7998 CNTO-1959, Tremfya®
GW274150 Immunopharmacology Ligand 9849 [2-[(1-iminoethyl) amino]ethyl]-L-homocysteine, GW-274150
GW3965 PDB Ligand Immunopharmacology Ligand 2754 C473027, GW 3965, GW-3965
GW406381 Immunopharmacology Ligand 9850 compound 8 [PMID: 15454242], GW-406381
GW 627368 Immunopharmacology Ligand 1953 GW-627368, GW627368, saccharic acid
GW766994 Immunopharmacology Ligand 9680 GSK766994, GW-766994
GYY4137 parent molecule Immunopharmacology Ligand 9808 GYY4137
 
H Back to top
H-151 Immunopharmacology Ligand 10122 H 151, H151
H4 antagonist 48 Immunopharmacology Ligand 9879
harmine PDB Ligand Immunopharmacology Ligand 9352
HG-9-91-01 PDB Ligand Immunopharmacology Ligand 8049 HY-15776
histamine PDB Ligand Immunopharmacology Ligand 1204
HpARI Immunopharmacology Ligand 9685 H. polygyrus Alarmin Release Inhibitor
H. polygyrus TGF-β mimic Immunopharmacology Ligand 9713 Hp-TGM
H2S Immunopharmacology Ligand 9532 hydrogen sulfide
hsp60 Immunopharmacology Ligand 4953 heat shock 60kD protein 1 (chaperonin), HSP-60, mitochondrial matrix protein P1
HsTX1[R14A] Immunopharmacology Ligand 9582 KTx 6.3
HTMT Immunopharmacology Ligand 1273 histamine-trifluoromethyl-toluidine, histamine-trifluoromethyltoluide, HTFMT
hydroxychloroquine Approved drug Immunopharmacology Ligand Antimalarial Ligand 7198 Dolquine®, Plaquenil®
6-Hydroxy-5,7-dimethoxyflavone Immunopharmacology Ligand 9878 UFM-24, UFM24
5-hydroxyindoleacetic acid PDB Ligand Immunopharmacology Ligand 11900
hydroxyzine Approved drug Immunopharmacology Ligand 7199 Atarax®, hydroxyzine hydrochloride, hydroxyzine pamoate, Vistaril®
 
I Back to top
ianalumab Immunopharmacology Ligand 10656 VAY-736, VAY736
ibalizumab Approved drug Immunopharmacology Ligand 10208 Hu5A8, ibalizumab-uiyk, TMB-355, TMB355, TNX-355, Trogarzo®
iberdomide PDB Ligand Immunopharmacology Ligand 9618 CC-220, compound 6 [PMID: 28425720]
iberiotoxin Immunopharmacology Ligand 4218 IbTX
ibritumomab tiuxetan Approved drug Immunopharmacology Ligand 6777 IDEC-2B8, IDEC-Y2B8-yttrium ibritumomab tiuxetan, NSC-715848, Zevalin®
ibrutinib Approved drug PDB Ligand Immunopharmacology Ligand 6912 Imbruvica®, PCI-32765
ibudilast Approved drug PDB Ligand Immunopharmacology Ligand 7399 AV-411, KC-404, Ketas®, MN-166
ibuprofen Approved drug Immunopharmacology Ligand 2713 Advil®, Brufen®, ibuprofen lysine, ibuprofen sodium, Motrin®, Nurofen®, U-18573
I-C11 Immunopharmacology Ligand 10374
IC-87114 PDB Ligand Immunopharmacology Ligand 9376 IC87114
icanbelimod PDB Ligand Immunopharmacology Ligand 12098 compound 2 [WO2015039587A1], S1p-receptor-agonist-1, YUN88562
IcatCXPZ-01 Immunopharmacology Ligand 11179 compound 8a [PMID: 30978322], XPZ-01
icatibant Approved drug Immunopharmacology Ligand 667 D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]BK, Firazyr®, HOE 140, HOE140
ICOS ligand Immunopharmacology Ligand 9593 CD275, B7 homolog 2, B7-H2, B7-related protein 1, B7RP-1, ICOS-L
icotrokinra Immunopharmacology Ligand 14181 JNJ-2113, JNJ-77242113, JNJ77242113
idelalisib Approved drug PDB Ligand Immunopharmacology Ligand 6741 CAL-101/CAL101, GS-1101, Zydelig®
ifidancitinib Immunopharmacology Ligand 10638 A-301, ATI-50002, ATI-502
IFN-α10 Immunopharmacology Ligand 4956 IFN alpha-10, interferon alpha-10, interferon alpha-6L, interferon alpha-C
IFN-α1/13 Immunopharmacology Ligand 4955 IFN-α1, IFN-α13, IFN-alpha 1/13, interferon alpha-1/13, interferon alpha-D
IFN-α14 Immunopharmacology Ligand 4957 IFN alpha-14, interferon alpha-14, interferon alpha-H, interferon lambda-2-H
IFN-α16 Immunopharmacology Ligand 4958 IFN alpha-16, interferon alpha-16, interferon alpha-WA
IFN-α17 Immunopharmacology Ligand 4959 IFN alpha-17, interferon alpha-17, interferon alpha-88, interferon alpha-T
IFN-α2 Approved drug Immunopharmacology Ligand 4960 IFN-alpha-2, interferon alpha-2, Roferon A®
IFN-α21 Immunopharmacology Ligand 4961 IFN-alpha 21, interferon alpha-21, interferon alpha-F
IFN-α4 Immunopharmacology Ligand 4962 IFN-alpha-4, interferon alpha-4 , interferon alpha-4B, interferon alpha-76, interferon alpha-M1
IFN-α5 Immunopharmacology Ligand 4963 IFN-alpha-5, interferon alpha-5, interferon alpha-61, interferon alpha-G
IFN-α6 Immunopharmacology Ligand 4964 IFN-alpha-6, interferon alpha-54, interferon alpha-6, interferon alpha-K
IFN-α7 Immunopharmacology Ligand 4965 IFN-alpha-7, interferon alpha-7, interferon alpha-J, interferon alpha-J1
IFN-α8 Immunopharmacology Ligand 4966 IFN-alpha-8, interferon alpha-8, interferon alpha-B, interferon alpha-B2
IFN-β Immunopharmacology Ligand 4967 Avonex® (recombinant IFN-beta-1a), fibroblast interferon, interferon beta
IFN-γ Approved drug Immunopharmacology Ligand 4968 Actimmune®, immune interferon, interferon gamma
IFN-κ Immunopharmacology Ligand 4969 interferon kappa
IFN-λ1 Immunopharmacology Ligand 4993 IFN-lambda-1, interferon lambda-1, interferon-λ1, interleukin-29
IFN-λ2 Immunopharmacology Ligand 4991 cytokine Zcyto20, IFN-lambda-2, interferon lambda-2, interferon-λ2, interleukin-28A
IFN-λ3 Immunopharmacology Ligand 4992 cytokine Zcyto22, IFN-lambda-3, IFN-lambda-4, interleukin-28B (IL-28B), interleukin-28C (IL-28C)
IFN-ω Immunopharmacology Ligand 4970 interferon alpha-II-1, interferon omega-1
IFN-β1b (recombinant human) Approved drug Immunopharmacology Ligand 8340 Betaferon®, Betaseron®, Extavia®, IFNb1b
IgE heavy chain Immunopharmacology Ligand 9557
iguratimod Approved drug PDB Ligand Immunopharmacology Ligand 9736 Careram®, Iremod, Kolbet®, T-614
IKK-beta inhibitor R-28 Immunopharmacology Ligand 10134 (R)-28, example 225 [US8372875B2]
IKK-2 inhibitor IV PDB Ligand Immunopharmacology Ligand 5986 TPCA-1, TPCA1
IL-10 Immunopharmacology Ligand 4975 interleukin-10
IL-11 Immunopharmacology Ligand 4976 interleukin-11
IL-12 Immunopharmacology Ligand 4977 IL-12 p70
IL-13 Immunopharmacology Ligand 4980 hematopoietic growth factor, interleukin-13, mast cell growth factor, multipotential colony-stimulating factor, P-cell-stimulating factor
IL-15 Immunopharmacology Ligand 4981 interleukin-15
IL-18 Immunopharmacology Ligand 4983 ibocatdekin, interferon-γ-inducing factor, interleukin-1 gamma (IL-1 gamma), interleukin-18
IL-19 Immunopharmacology Ligand 4984 interleukin-19, melanoma differentiation-associated protein-like protein
IL-1α Immunopharmacology Ligand 4973 hematopoietin-1, interleukin-1 alpha
IL-1β Immunopharmacology Ligand 4974 catabolin, interleukin-1 beta
IL-2 Approved drug Immunopharmacology Ligand 4985 aldesleukin, interleukin-2, Proleukin®
IL-20 Immunopharmacology Ligand 4986 cytokine Zcyto10, interleukin-20
IL-21 Immunopharmacology Ligand 4987 interleukin-21, ZA11
IL-22 Immunopharmacology Ligand 4988 cytokine Zcyto18, interleukin-22
IL-23 Immunopharmacology Ligand 4978
IL-24 Immunopharmacology Ligand 4990 interleukin-24, MDA-7, melanoma differentiation-associated gene 7 protein
IL-25 Immunopharmacology Ligand 5876 IL-17E, interleukin-17E, interleukin-25
IL-27 Immunopharmacology Ligand 6151
IL-3 Immunopharmacology Ligand 4994 interleukin-3 (IL-3), multilineage-colony-stimulating factor (mCSF)
IL-31 Immunopharmacology Ligand 4995 interleukin-31
IL-33 Immunopharmacology Ligand 5880 IL-1F11
IL-34 Immunopharmacology Ligand 8975
IL-36α Immunopharmacology Ligand 5881 FIL1 epsilon, interleukin-1 epsilon (IL-1 epsilon)
IL-36β Immunopharmacology Ligand 5882 FIL1 eta, IL-1 eta, interleukin-1 eta
IL-36γ Immunopharmacology Ligand 5883 IL-1-related protein 2 (IL-1RP2), interleukin-1 epsilon (IL-1E), interleukin-1 family member 9, interleukin-36 gamma
IL-37 Immunopharmacology Ligand 6149 IL-1ζ, IL-23, interleukin-1ζ, interleukin-1-related protein (IL1RP), interleukin-23
IL-4 Immunopharmacology Ligand 4996 B-cell stimulatory factor 1, binetrakin, interleukin-4, pitrakinra
IL-5 Immunopharmacology Ligand 4997
IL-6 Immunopharmacology Ligand 4998 B-cell stimulatory factor 2, CTL differentiation factor, hybridoma growth factor, interferon β2, interleukin-6
IL-7 Immunopharmacology Ligand 4999 interleukin-7
IL-9 Immunopharmacology Ligand 5000 interleukin-9
IL-12A Immunopharmacology Ligand 5001 IL-12 p35, interleukin-12A, NKSF1
IL-17A Immunopharmacology Ligand 4982 CTLA-8, interleukin-17 alpha
IL-23A Immunopharmacology Ligand 4989 IL-23p19, IL23A, interleukin-23 subunit alpha, interleukin-23A
IL-17A/IL-17F Immunopharmacology Ligand 5874
IL-12B Immunopharmacology Ligand 5002 IL-12 p40, IL-12B monomer, interleukin-12β, interleukin-12B, natural killer cell stimulatory factor 2
IL-17B Immunopharmacology Ligand 5877
IL-17C Immunopharmacology Ligand 5875 cytokine CX2, interleukin-17C
IL-17F Immunopharmacology Ligand 5873 cytokine ML-1, Interleukin-17F
iloprost Approved drug Immunopharmacology Ligand 1895 Aurlumyn®, Ventavis®
IL-1 receptor antagonist Immunopharmacology Ligand 5878 IL-1ra, interleukin-1 receptor antagonist protein, IRAP
IL-36 receptor antagonist Immunopharmacology Ligand 5879 IL-1 related protein 3 (IL1RP3), IL-1F5, IL-36ra, IL1F5, interleukin 1 family member 5 (delta)
IL-27 subunit α Immunopharmacology Ligand 6152 IL-27 subunit alpha, interleukin-27 subunit alpha, p28
IL-27 subunit β Immunopharmacology Ligand 6153 EBV-induced gene 3 protein, Epstein-Barr virus-induced gene 3 protein, IL-27 subunit beta, IL-27B, interleukin-27 subunit beta
imaprelimab Immunopharmacology Ligand 9805 PRX-003, PRX003
imaradenant PDB Ligand Immunopharmacology Ligand 11153 AZD-4635, AZD4635
imatinib Approved drug PDB Ligand Immunopharmacology Ligand 5687 CGP 57148, Gleevec®, Glivec®, STI571
imetit PDB Ligand Immunopharmacology Ligand 1250
imiquimod Approved drug PDB Ligand Immunopharmacology Ligand 5003 Aldara®, R837, S-26308, Zyclara®
immepip PDB Ligand Immunopharmacology Ligand 1251
impromidine Immunopharmacology Ligand 1226 SK&F-92676-A3
INCB3284 Immunopharmacology Ligand 9045 compound 13 [PMID: 24900329], INCB 3284
INCB8761 Immunopharmacology Ligand 9032 compound 17 [PMID: 24900280], INCB-8761, PF-4136309, PF4136309
inclacumab Immunopharmacology Ligand 12312 HuMab 002, LC1004-002, RO-4905417, RO4905417
indacaterol Approved drug Immunopharmacology Ligand 7455 Arcapta Neohaler®, Onbrez®, QAB-149, QAB149
indole-3-carbinol PDB Ligand Immunopharmacology Ligand 10047 3-hydroxymethylindole, 3-indolemethanol, 3-indolylcarbinol, I3C
indomethacin Approved drug PDB Ligand Immunopharmacology Ligand 1909 Indocid®, Indocin®
infliximab Approved drug Immunopharmacology Ligand 5004 cA2, Inflectra®, Remicade®, Remsima®, SB2, TA-650, Zymfentra® (subcutaneous formulation)
inhibitor M9 [PMID: 38236416] Immunopharmacology Ligand 13113
inhibitor 32 [PMID: 29620892] Immunopharmacology Ligand 9898
inotuzumab ozogamicin Approved drug Immunopharmacology Ligand 8266 Besponsa®, CMC-544
interleukin 18 binding protein Immunopharmacology Ligand 13868
ipilimumab Approved drug Immunopharmacology Ligand 6888 MDX-010, MDX-101, MDX-CTLA-4, Yervoy®
ipratropium Approved drug Immunopharmacology Ligand 325 Atrovent®, Ipraxa®
iptacopan Approved drug PDB Ligand Immunopharmacology Ligand 10710 compound 41 [PMID: 32073845], Fabhalta®, LNP-023, LNP023
IRAK-1/4 inhibitor Immunopharmacology Ligand 5990
IRAK4 inhibitor 4b [PMID: 18474425] PDB Ligand Immunopharmacology Ligand 8080
IRAK4 inhibitor rac-45 [PMID: 18501603] Immunopharmacology Ligand 8081
iscalimab Immunopharmacology Ligand 9802 CFZ-533, CFZ533, NVP-CFZ533, OM11-62MF
ISO-1 Immunopharmacology Ligand 9984 IN1228
isoetarine Approved drug Immunopharmacology Ligand 7205 Bronkometer®, Bronkosol®, WIN-3406
isothiourea-1t PDB Ligand Immunopharmacology Ligand 2899 IT1t
isunakinra Immunopharmacology Ligand 9704 EBI-005
itacitinib PDB Ligand Immunopharmacology Ligand 8364 Examlpe 294 [WO2011112662], INCB-039110
itolizumab Approved drug Immunopharmacology Ligand 9421 Alzumab®, T1h
ivarmacitinib Approved drug Immunopharmacology Ligand 11878 example 34 [WO2013091539A1], SHR-0302, SHR0302
ivonescimab Approved drug Immunopharmacology Ligand 13396 AK-112, AK112, Idafang® (China), SMT-112, SMT112
ixekizumab Approved drug Immunopharmacology Ligand 7541 LY-2439821, LY2439821, Taltz®
izencitinib Immunopharmacology Ligand 10458 example 1 [WO2016191524A1], JNJ-8398, JNJ8398, TD-1473, TD1473
 
J Back to top
JAK3 inhibitor 32 Immunopharmacology Ligand 10156 compound 32 [PMID: 30423248]
JAK3 inhibitor 34 PDB Ligand Immunopharmacology Ligand 10157 compound 34 [PMID: 30423248]
JAK inhibitor 20a Immunopharmacology Ligand 10147
JAK inhibitor 17b Immunopharmacology Ligand 10148
JNJ-10191584 Immunopharmacology Ligand 1277 compound 12, JNJ 10191584, VUF 6002, VUF6002
JNJ-10311795 Immunopharmacology Ligand 6563
JNJ-27141491 Immunopharmacology Ligand 10586 JNJ27141491
JNJ-39758979 Immunopharmacology Ligand 8984 JNJ 39758979, JNJ39758979
JNK inhibitor IX Immunopharmacology Ligand 5996 AC1LG8KT, BAS 01816608, TCS JNK 5a
JR14a PDB Ligand Immunopharmacology Ligand 10595
 
K Back to top
KA1010 Immunopharmacology Ligand 9663
KBP-7018 Immunopharmacology Ligand 9691 compound 3 [Huang et al., 2017]
ketoprofen Approved drug Immunopharmacology Ligand 4795 Actron®, Orudis®
ketorolac Approved drug Immunopharmacology Ligand 6661 Acular®, Toradol®
KML29 Immunopharmacology Ligand 9482
KT-109 Immunopharmacology Ligand 10245 KT109
KT-474 Immunopharmacology Ligand 12892 Compound A [WO2022174269A1], KT474
 
L Back to top
L-798,106 Immunopharmacology Ligand 1941 L-798106, L798106
labuxtinib Immunopharmacology Ligand 12870 Compound 1 [WO2022109595], example F91 [WO2013033070], THB-335, THB335
lanraplenib PDB Ligand Immunopharmacology Ligand 9764 compound 39 [PMID: 32292557], Ex.-2, US9290505, example 2 [US9290505], GS-9876, GS9876
Large proline-rich protein BAG6 Immunopharmacology Ligand 11143 BAG6
LASSBio-1524 Immunopharmacology Ligand 11066
LASW1393 PDB Ligand Immunopharmacology Ligand 10527 compound 34 [PMID: 31609613], LASW-1393
lazucirnon Immunopharmacology Ligand 10653 AKST-4290, AKST4290, ALK-4290, ALK4290, Example 11 [WO2012045803A1]
lebrikizumab Approved drug Immunopharmacology Ligand 7684 Ebglyss®, lebrikizumab-lbkz, MILR1444A, RG3637, TNX-650
leflunomide Approved drug Immunopharmacology Ligand 6825 Arabloc®, Arava®, HWA 486, HWA-486, lefunamide, SU-101
lenabasum PDB Ligand Immunopharmacology Ligand 9772 ajulemic acid, CPL-7075, CPL7075, CT-3, IP-751, IP751
lenalidomide Approved drug Immunopharmacology Ligand 7331 CC-5013, CDC-501, Revlimid®
leniolisib Approved drug PDB Ligand Immunopharmacology Ligand 9424 CDZ-173, CDZ173, Example 67 [WO2012004299], Joenja®
lenzilumab Immunopharmacology Ligand 8935 KB-003, KB003
LEO 134310 Immunopharmacology Ligand 11901 LEO-134310, LEO134310
LEO 239652 PDB Ligand Immunopharmacology Ligand 12725 compound 40 [PMID: 33054196], LEO-239652, LEO239652
LEO 29102 Immunopharmacology Ligand 12724 compound 20 [PMID: 24984230], LEO-29102, LEO29102
L-161,982 (EP4A) Immunopharmacology Ligand 1952 EP4A, L-161982, L161982
lepzacitinib Immunopharmacology Ligand 12871 example 117 [WO2019090158A1]
leronlimab Immunopharmacology Ligand 10752 PRO 140, PRO-140, PRO140, Vyrologix®
lestaurtinib PDB Ligand Immunopharmacology Ligand 5672 CEP-701, KT-5555, SP924
levosalbutamol Approved drug PDB Ligand Immunopharmacology Ligand 9816 (-)-albuterol, (-)-salbutamol, (R)-salbutamol, levalbuterol, Xopenex®
LFM-A13 Immunopharmacology Ligand 9262 α-cyano-beta-hydroxy-β-methyl-N-(2, 5-dibromophenyl)propenamide, alpha-cyano-beta-hydroxy-beta-methyl-N-(2, 5-dibromophenyl)propenamide
L6H21 Immunopharmacology Ligand 9027
LHVS Immunopharmacology Ligand 9298 morpholinurea-leucine-homophenylalanine-vinylsulfone-phenyl, morpholinurea-leucine-homophenylalaninevinyl phenyl sulfone
LIF Immunopharmacology Ligand 5016 cholinergic differentiation factor (CDF), differentiation-inducing factor (DIF), human interleukin in DA cells (HILDA)
lifitegrast Approved drug Immunopharmacology Ligand 7533 compound 1g [PMID: 24900456], SAR 1118, SAR-1118, SAR-1118-023, Xiidra®
ligelizumab Immunopharmacology Ligand 8997 CL-2C, NVP-QGE031, QGE031
LIGHT Immunopharmacology Ligand 5070 Herpesvirus entry mediator-ligand, TR2
ligufalimab Immunopharmacology Ligand 13887 AK-117, AK117
lilotomab Immunopharmacology Ligand 9950 Betalutin®, HH1, tetulomab
linrodostat Immunopharmacology Ligand 9707 BMS-986205, BMS986205, Compound 2 [PMID: 29531094], Example 19 [US20160137652A1]
lintuzumab Immunopharmacology Ligand 7983 ACTIMAB®, HuM195, SGN-33, SMART M195
(S)-liquiritigenin PDB Ligand Immunopharmacology Ligand 8899
lirilumab Immunopharmacology Ligand 9310 1-7F9, BMS-986015, IPH2102
lisofylline Immunopharmacology Ligand 9225 (R)-lisophylline, CT-1501R
LIT-927 Immunopharmacology Ligand 10075 compound 57 [PMID: 30106292]
litifilimab Immunopharmacology Ligand 11122 BIIB-059, BIIB059
liver enriched antimicrobial peptide 2 Immunopharmacology Ligand 9734 LEAP2
LL-37 Immunopharmacology Ligand 5527 antibacterial protein LL-37, cathelicidin LL 37 (human)
LM10 Immunopharmacology Ligand 9016 LM-10
lodoxamide Approved drug PDB Ligand Immunopharmacology Ligand 9743 Alomide®
lomedeucitinib Immunopharmacology Ligand 13210 BMS-986322, BMS986322, example 252 [US20210253554]
londamocitinib Immunopharmacology Ligand 11716 AZD-4604, AZD4604, example 35 [WO2018134213A1], Jak1-IN-7
lonodelestat Immunopharmacology Ligand 11275 cyclo[Ala-Ser-Ile-Pro-Pro-Gln-Lys-Tyr-D-Pro-Pro-Nle(Bu)-Glu-Thr], POL-6014, POL6014
loratadine Approved drug Immunopharmacology Ligand 7216 Claritin®, SCH-29851
lorecivivint Immunopharmacology Ligand 9620 adavivint (deprecated INN), SM0-4690, SM04690
losmapimod Immunopharmacology Ligand 7835 GS856553, GW856553
loteprednol etabonate Approved drug Immunopharmacology Ligand 7085 HGP-1, Inveltys®, Lotemax®, P-5604
lovastatin Approved drug PDB Ligand Immunopharmacology Ligand 2739 (+)-mevinolin, 6α-methylcompactin, Mevacor®
5-LOX activating protein Immunopharmacology Ligand 5183 FLAP, 5-lipoxygenase-activating protein, arachidonate 5-lipoxygenase-activating protein
5-LOX inhibitor 2m [PMID: 30199704] Immunopharmacology Ligand 10079
LTB4 PDB Ligand Immunopharmacology Ligand 2487 leukotriene B4
lulizumab pegol Immunopharmacology Ligand 8460 BMS-931699, BMS931699
lumiracoxib Approved drug PDB Ligand Immunopharmacology Ligand 2897 Prexige®
lutikizumab Immunopharmacology Ligand 9297 ABT-981, E26.13-SS-X3
LW106 Immunopharmacology Ligand 9940
LX2931 Immunopharmacology Ligand 9851 LX3305
LXB4 Immunopharmacology Ligand 5216 lipoxin B4
LY255283 Immunopharmacology Ligand 3351 CGS 23356, LY 255283, LY-255283
LY3022855 Immunopharmacology Ligand 9109 IMC-CS4
LY3023703 PDB Ligand Immunopharmacology Ligand 12211 compound 9 [PMID: 25260492]
LY3509754 Immunopharmacology Ligand 13164
lymphotoxin-α Immunopharmacology Ligand 5064 TNFSF1, LTα, TNFβ
LYS006 PDB Ligand Immunopharmacology Ligand 11205 LYS-006
 
M Back to top
3M-002 PDB Ligand Immunopharmacology Ligand 9270 CL-075, CL075
MAB92 Immunopharmacology Ligand 9665
macrophage migration inhibitory factor Immunopharmacology Ligand 9981 L-dopachrome isomerase, MMIF
magrolimab Immunopharmacology Ligand 12652 Hu5F9-G4
MAPK13-IN-1 PDB Ligand Immunopharmacology Ligand 11096 compound 61 [WO2014015056A2]
mapracorat Immunopharmacology Ligand 9654 BOL-303242-X, ZK-245186, ZK245186
maraviroc Approved drug Immunopharmacology Ligand 806 Celsentri®, Selzentry®, UK 427857, UK-427,857
marbostat-100 Immunopharmacology Ligand 9891 compound 5a [PMID: 29589441]
maresin 1 Immunopharmacology Ligand 12056 7R,14S-dihydroxydocosa-4Z,8E,10E,12Z,16Z,19Z-hexaenoic acid, 7R-Maresin 1, MaR1, Maresin-1
maresin 2 Immunopharmacology Ligand 12055 13R,14S-diHDHA, 13R,14S-dihydroxy-docosahexaenoic acid, MaR2, maresin-2
masitinib PDB Ligand Immunopharmacology Ligand 5656 AB-1010, AB1010, Masican® (proposed trade name)
mavorixafor Approved drug PDB Ligand Immunopharmacology Ligand 8580 AMD 070, AMD-070, AMD-11070, AMD11070, compound 2 [PMID: 20297846], X4P-001, X4P-001-IO, X4P-001-LD, Xolremdi®
mavrilimumab Immunopharmacology Ligand 7785 CAM-3001, KPL-301
MCC950 PDB Ligand Immunopharmacology Ligand 8228 CP-456,773, CP-456773, CRID3, MCC-950
MCS110 Immunopharmacology Ligand 9110
M-CSF Immunopharmacology Ligand 4905 CSF-1, lanimostim, macrophage-CSF
MDG 548 Immunopharmacology Ligand 9888 compound 1 [PMID: 22582973], MDG-548, MDG548
meclofenamic acid Approved drug PDB Ligand Immunopharmacology Ligand 7219 CL-583, INF-4668, Meclomen®
medrysone Approved drug Immunopharmacology Ligand 7086 U-8471
mefenamic acid Approved drug PDB Ligand Immunopharmacology Ligand 2593 CI-473, CN-35355, INF-3355, Ponstan®, Ponstel®
melatonin Approved drug PDB Ligand Immunopharmacology Ligand 224 MLT, Circadin®
meloxicam Approved drug PDB Ligand Immunopharmacology Ligand 7220 Mobic®, UHAC-62XX
mepacrine PDB Ligand Immunopharmacology Ligand Antimalarial Ligand 10172 Atabrine®, quinacrine
mepolizumab Approved drug Immunopharmacology Ligand 7685 Nucala®, SB-240563
mepyramine Approved drug PDB Ligand Immunopharmacology Ligand 1227 Anthisan®, mepiramine, mepyramine maleate, pyrilamine, pyrilamine tannate, Pyrlex®
merestinib PDB Ligand Immunopharmacology Ligand 9841 LY-2801653, LY2801653
MerTK inhibitor 11 Immunopharmacology Ligand 13918
mesalazine Approved drug Immunopharmacology Ligand 2700 5-aminosalicylic acid, 5-ASA, mesalamine (USAN), Pentasa®
[Met]enkephalin Immunopharmacology Ligand 1614 1-5 Adrenorphin, [Met]-enkephalin, IRT-101, methionine enkephalin, np2 enkephalin, opioid growth factor (OGF)
metformin Approved drug PDB Ligand Immunopharmacology Ligand 4779 Glucophage®, LA-6023
methacholine Approved drug Immunopharmacology Ligand 7438 methacholine bromide, Provocholine®
methimazole Approved drug PDB Ligand Immunopharmacology Ligand 6649 Tapazole®, Thiamazole®
methotrexate Approved drug PDB Ligand Immunopharmacology Ligand 4815 Abitrexate®, amethopterin, Nordimet®, Rasuvo®
(R)-α-methylhistamine Immunopharmacology Ligand 1236 (R)-α-MeHA, alpha-methylhistamine
methylprednisolone Approved drug Immunopharmacology Ligand 7088 Medrol®, U-67590A
mezagitamab Immunopharmacology Ligand 10609 TAK-079, TAK079
MIDD0301 Immunopharmacology Ligand 9890
midostaurin Approved drug PDB Ligand Immunopharmacology Ligand 5702 CGP 41231, CGP 41251, N-benzoylstaurosporine, PKC412, Rydapt®
mifepristone Approved drug PDB Ligand Immunopharmacology Ligand 2805 Mifeprex®, RU-486, RU486
MIF inhibitor 3bb PDB Ligand Immunopharmacology Ligand 9986
milategrast Immunopharmacology Ligand 10463 example 9 [US20050261291A1]
milatuzumab Immunopharmacology Ligand 8267 hLL1, IMMU-115
miltefosine Approved drug Immunopharmacology Ligand 11355 D-18506, D18506, Impavido®, Miltex®, n-hexadecylphosphorylcholine
mirikizumab Approved drug Immunopharmacology Ligand 9846 Antibody I [US9023358], LY-3074828, LY3074828, mirikizumab-mrkz, Omvoh®
mivavotinib PDB Ligand Immunopharmacology Ligand 9600 compound 3b [PMID: 27839918], TAK-659, TAK659
mizolastine Approved drug Immunopharmacology Ligand 10102 Mizollen®, MKC-431, MKC431, SL 85.0324, SL-850324, SL850324
MK-0359 Immunopharmacology Ligand 9852 L-454,560, L-454560, MK0359
MK-0812 Immunopharmacology Ligand 9048 MK0812
MK-0873 Immunopharmacology Ligand 9853 compound 20 [PMID: 18835163], MK0873
MK-7110 Immunopharmacology Ligand 11395 CD24-Fc, CD24Fc
MK-886 PDB Ligand Immunopharmacology Ligand 2655 L 663536, MK886
ML130 Immunopharmacology Ligand 8887 compound 1c [PMID: 22003428], ML-130, Noditinib-1
ML324 Immunopharmacology Ligand Antimalarial Ligand 9584 ML-324, MMV1580488
MLN-120B Immunopharmacology Ligand 5694 ML120B, MLN120B
ML2-SA1 Immunopharmacology Ligand 10301 EVP-22, EVP22, ML2 SA1, ML2SA1
MM-433593 Immunopharmacology Ligand 9944 MM433593
MMK-1 Immunopharmacology Ligand 6240 MMK 1
mocravimod Immunopharmacology Ligand 9727 compound 2 [PMID: 23124563], KRP-203, KRP203
mocravimod-phosphate Immunopharmacology Ligand 2923 KRP 203-phosphate, KRP203-phosphate
mofegiline Immunopharmacology Ligand 9754 MDL 72974, MDL-72,974, MDL-72974A
mogamulizumab Approved drug Immunopharmacology Ligand 6477 KW-0761, mogamulizumab-kpkc, Poteligeo®
molibresib PDB Ligand Immunopharmacology Ligand 7033 CS-0717, GSK 525762A, GSK-525762, GSK525762, I-BET-762, I-BET762
mometasone Approved drug Immunopharmacology Ligand 9029 Elocon® (topical), Nasonex®
monalizumab Immunopharmacology Ligand 8323 humZ270, IPH-2201, NN8765-3658
mongersen Immunopharmacology Ligand 8277 DNA, d(P-thio)(G-T-m5C-G-C-C-C-C-T-T-C-T-C-C-C-m5C-G-C-A-G-C), GED-0301, GED0301
monomethyl fumarate PDB Ligand Immunopharmacology Ligand 5786 methyl hydrogen fumarate
montelukast Approved drug PDB Ligand Immunopharmacology Ligand 3340 Singulair®
mosedipimod Immunopharmacology Ligand 9771 EC-18, Plag, (+/-)
motixafortide Approved drug Immunopharmacology Ligand 10679 4F-Benzoyl-TN14003, Aphexda®, BKT140, BL-8040, TF14016
motolimod Immunopharmacology Ligand 9026 VTX-2337
moxetumomab pasudotox Approved drug Immunopharmacology Ligand 7675 CAT-8015, GCR-8015, HA22, Lumoxiti®, moxetumomab pasudotox-tdfk
MPI-0485520 Immunopharmacology Ligand 9580 MPC-9528, MPI-485520
MPPA Immunopharmacology Ligand 9897 inhibitor 23 [PMID: 29614224]
MRI-1867 Immunopharmacology Ligand 10521 (-)-MRI-1867, MRI1867
MRL-248 Immunopharmacology Ligand 9080
MRL-367 Immunopharmacology Ligand 9079
MRL-871 PDB Ligand Immunopharmacology Ligand 10642 MRL871
MRS2578 Immunopharmacology Ligand 1753 MRS 2578, MRS-2578
MRS4458 Immunopharmacology Ligand 9998 compound 20 [Yu et al., 2018]
MRS4478 Immunopharmacology Ligand 9999 compound 30 [Yu et al., 2018]
MRT67307 PDB Ligand Immunopharmacology Ligand 8062 MRT-67307
mucosal addressin cell adhesion molecule 1 Immunopharmacology Ligand 9339 MAdCAM-1, addressin, MAdCAM1
muromonab-CD3 Approved drug Immunopharmacology Ligand 6889 L04AA02, OKT-3, Orthoclone Okt3®
MW150 PDB Ligand Immunopharmacology Ligand 10524 compound 11 [PMID: 30978288], compound 27 [WO2014145485A2], compound 8 [PMID: 25676389], MW-150, MW01-18-150SRM
mycophenolate mofetil Approved drug Immunopharmacology Ligand 6831 Cellcept®, RS-61443, RS-61443-190
 
N Back to top
nabumetone Approved drug PDB Ligand Immunopharmacology Ligand 7245 BRL-14777, Relafen®
nacresertib Immunopharmacology Ligand 13502 compound 001 [WO2021057785]
namilumab Immunopharmacology Ligand 10370 AMG203, MT203
naproxcinod Immunopharmacology Ligand 9551 AZD-3582, AZD3582, HCT-3012, NO-naproxen
naproxen Approved drug PDB Ligand Immunopharmacology Ligand 5230 (S)-naproxen, Aleve®, Naprosy®
naptumomab estafenatox Immunopharmacology Ligand 9948 ABR-217620, ABR217620, Anyara (proposed trade name), TTS CD3, TTS-CD3
naratuximab emtansine Immunopharmacology Ligand 9949 IMGN-529, IMGN529, K7153A-SMCC-DM1
natalizumab Approved drug Immunopharmacology Ligand 6591 AN100226, anti-alpha4 integrin, anti-VLA4, Tysabri®
Natural cytotoxicity triggering receptor 3 ligand 1 Immunopharmacology Ligand 11142 B7H6, B7-H6
navamepent Immunopharmacology Ligand 9463 RX-10045
navarixin Immunopharmacology Ligand 8497 MK-7123, MK7123, SCH-527123, SCH527123
navoximod PDB Ligand Immunopharmacology Ligand 9019 GDC-0919, NLG-919, NLG919, RG6078
NBI-74330 Immunopharmacology Ligand 839 (±)-NBI 74330, NBI74330
NC1 Immunopharmacology Ligand 10373
NCX-4016 Immunopharmacology Ligand 9018 NCX 4016, NCX4016, nitric oxide-releasing aspirin, nitroaspirin
ND-2110 PDB Ligand Immunopharmacology Ligand 8082
ND-2158 Immunopharmacology Ligand 8083
NDT-19795 Immunopharmacology Ligand 13009 NDT19795
NDT9513727 PDB Ligand Immunopharmacology Ligand 9746 NDT 9513727, NDT-9513727
necrostatin-1 Immunopharmacology Ligand 9750 methyl-thiohydantoin-tryptophan, MTH-DL-tryptophan, MTH-trp, nec-1, Necrostatin 1
necrostatin-1s Immunopharmacology Ligand 9751 7-Cl-O-Nec-1, nec-1s, necrostatin 2 racemate
nedocromil Approved drug Immunopharmacology Ligand 7607 FPL-59002, nedocromil sodium, Rapitil®, Tilade®
neflamapimod PDB Ligand Immunopharmacology Ligand 5719 VD-31745, VRT-031745, VX 745, VX-745
nemiralisib PDB Ligand Immunopharmacology Ligand 9425 compound 2 [PMID: 26301626], GSK-2269557, GSK2269557
nemolizumab Approved drug Immunopharmacology Ligand 8720 CD14152, CIM 331, CIM331, Mitchga®, Nemluvio®
neoceptin-3 PDB Ligand Immunopharmacology Ligand 9137
neoceptin-4 Immunopharmacology Ligand 9138
NE 52-QQ57 PDB Ligand Immunopharmacology Ligand 10206 example 35 [WO2012131633A1], GPR4 antagonist 13, NE52-QQ57
nerandomilast Immunopharmacology Ligand 12518 BI 1015550, BI-1015550, BI1015550
α-NETA Immunopharmacology Ligand 9781
Nexinhib20 Immunopharmacology Ligand 9419
nezulcitinib Immunopharmacology Ligand 11304 example 1 [WO2020051105A1]
NF-56-EJ40 PDB Ligand Immunopharmacology Ligand 10519
nibrozetone Immunopharmacology Ligand 13184 ABDNAZ, RRx-001, RRx001
niflumic acid Approved drug PDB Ligand Immunopharmacology Ligand 2439
NIK inhibitor 12f Immunopharmacology Ligand 10947
NIK SMI1 Immunopharmacology Ligand 9964
nimesulide Approved drug PDB Ligand Immunopharmacology Ligand 7401 R-805
nivolumab Approved drug Immunopharmacology Ligand 7335 BMS-936558, MDX-1106, ONO-4538, Opdivo®
NK7-902 Immunopharmacology Ligand 14003
N-methyl-2-pyrrolidone PDB Ligand Immunopharmacology Ligand 9520 NMP, N-methyl-pyrrolidone
6-n-octylaminouracil Immunopharmacology Ligand 5846 6-n-octyl aminouracil
NP3-253 PDB Ligand Immunopharmacology Ligand 13645 compound 16 [PMID: 39574318], NP3253
NPT520-34 Immunopharmacology Ligand 13271 compound 1 [WO2019246454]
NS-398 PDB Ligand Immunopharmacology Ligand 8976 NS 398
NS6180 Immunopharmacology Ligand 9318
NS6740 Immunopharmacology Ligand 11383 A-793394, A793394, NS-6740
NSC61610 Immunopharmacology Ligand 10364
NSC80734 Immunopharmacology Ligand 10497
NT-0249 Immunopharmacology Ligand 13338 NT0249
NT-0796 Immunopharmacology Ligand 13008 NT0796
nurulimab Immunopharmacology Ligand 12992 BCD-145, BCD145
NX-2127 Immunopharmacology Ligand 12519
 
O Back to top
obatoclax Immunopharmacology Ligand 11086 GX-15-070, GX15-070, obatoclax mesylate, SB16622
obinutuzumab Approved drug Immunopharmacology Ligand 6941 GA-101, GA101, Gazyva®
ocadusertib Immunopharmacology Ligand 13504 compound I-30 [WO2021046407], LY-3871801, LY3871801, R-552, R552
ocipumaltib Immunopharmacology Ligand 14050 compound A [WO2023149450A1], CTX-177, CTX177
oclacitinib Immunopharmacology Ligand 9696 Apoquel® (veterinary use), PF-03394197
ocrelizumab Approved drug Immunopharmacology Ligand 7580 2H7, Ocrevus®, PRO70769, RG1594
17-octadecynoic acid Immunopharmacology Ligand 8851 17-ODYA
OD36 PDB Ligand Immunopharmacology Ligand 10406
ofatumumab Approved drug Immunopharmacology Ligand 6778 Arzerra®, GSK 1841157, GSK1841157, humax-CD20, Kesimpta® (subcutaneous), OMB-157, OMB157
ofirnoflast Immunopharmacology Ligand 13227 example 10 [WO2021242505]
olamkicept Immunopharmacology Ligand 9729 FE 999301, FE-301, FE-999301, TJ301
olaptesed pegol Immunopharmacology Ligand 9674 NOX-A12
oleclumab Immunopharmacology Ligand 9596 MEDI 9447, MEDI-9447
olinciguat Immunopharmacology Ligand 10213 IW-1701, IW1701
olodaterol Approved drug PDB Ligand Immunopharmacology Ligand 7543 BI-1744, BI-1744-CL, Striverdi®
olopatadine Approved drug Immunopharmacology Ligand 7249 ALO-4943A, KW-4679, Opatanol®, Patanol®, Pazeo®
olverembatinib Approved drug PDB Ligand Immunopharmacology Ligand 10630 compound 10a [PMID: 23301703], GZD-824, GZD824, HQP-1351, HQP1351
omalizumab Approved drug Immunopharmacology Ligand 6890 IGE25, olizumab, R03DX05, RG-3648, rhumab-E25, Xolair®
omaveloxolone Approved drug Immunopharmacology Ligand 7573 RTA 408, RTA-408, Skyclarys®
4-OMe-ARM1 PDB Ligand Immunopharmacology Ligand 10562 compound 7 [PMID: 31751136]
omilancor Immunopharmacology Ligand 10363 analogue 7 [PMID: 27933891], BT-11, BT11, Example 1 [US9556146B2]
omipalisib PDB Ligand Immunopharmacology Ligand 8974 GSK 2126458, GSK-2126458, GSK2126458
onfekafusp alfa Immunopharmacology Ligand 9757 Daramun (bifikafusp alfa and onfekafusp alfa), Fibronum, L19TNF-alpha, Nidlegy (bifikafusp alfa and onfekafusp alfa)
ONO-AE3-208 Immunopharmacology Ligand 1942 ONO AE3 208
ontamalimab Immunopharmacology Ligand 9340 PF-00547659, PF-547659, SHP647
ONX-0914 Immunopharmacology Ligand 9031 PR-957
oprelvekin Approved drug Immunopharmacology Ligand 6971 Neumega®
ordesekimab Immunopharmacology Ligand 13046 AMG-714, AMG714, MAb146B7, PRV-015
orelabrutinib Approved drug Immunopharmacology Ligand 10629 example 3 [WO2015048662A2], ICP-022, ICP022
ORG 214007-0 Immunopharmacology Ligand 11310 [(-)-N-(2S,10S,14bS)]-N-(8-cyano-1,2,3,4,10,14b-hexahydro-10-methyl dibenzo[c,f]pyrido[1,2-a]azepin-2-yl)-4-methyl-1,2,3-thiadiazole-5-carboxamide]], ORG214007-0
Orita-13 PDB Ligand Immunopharmacology Ligand 9985 compound 13 [PMID: 11170644]
oroxylin A Immunopharmacology Ligand 13522
OSE-127 Immunopharmacology Ligand 9604 Effi-7
osthole PDB Ligand Immunopharmacology Ligand 10302 7-Methoxy-8-isopentenylcoumarin, osthol
otenaproxesul Immunopharmacology Ligand 9534 ATB 346, ATB-346, ATB-346, (S)-, ATB346
otilimab Immunopharmacology Ligand 11132 GSK-3196165, GSK3196165, MOR-103, MOR103
otlertuzumab Immunopharmacology Ligand 9951 CD37-SMIP, TRU-016, TRU016
oxaprozin Approved drug PDB Ligand Immunopharmacology Ligand 7252 Daypro®, WY-21743
OX-40 ligand Immunopharmacology Ligand 5076 glycoprotein Gp34, TXGP-1
ozagrel Approved drug Immunopharmacology Ligand 9866 Cataclot®, KCT-0809, OKY-046, Pulmoza®
ozanimod Approved drug PDB Ligand Immunopharmacology Ligand 8709 RPC-1063, RPC1063, Zeposia®
ozoralizumab Immunopharmacology Ligand 9638 ATN-103, PF-5230896
 
P Back to top
P505-15 PDB Ligand Immunopharmacology Ligand 8070 BIIB057, PRT-062607, PRT062607
pacibekitug Immunopharmacology Ligand 14206 PF 4236921, PF-4236921, PF04236921, TOUR-006, TOUR006
PAF PDB Ligand Immunopharmacology Ligand 1831 PAF (C16), PAF C-16, platelet activating factor
pamapimod PDB Ligand Immunopharmacology Ligand 9915 compound 2b [PMID: 21375264], Ro 4402257, Ro-4402257, Ro4402257
Pam2CSK4 Immunopharmacology Ligand 8560
Pam3CSK4 Immunopharmacology Ligand 8558
parecoxib Approved drug PDB Ligand Immunopharmacology Ligand 2895 Dynastat®, SC-69124
paridiprubart Immunopharmacology Ligand 13714 EB05, NI 0101, NI-0101
parsaclisib Immunopharmacology Ligand 10098 compound 20 [PMID: 31749910], IBI376, INCB-050465
pascolizumab Immunopharmacology Ligand 7786 SB-240683
pateclizumab Immunopharmacology Ligand 9854 MLTA3698A, PRO283698, RG7416
patritumab deruxtecan Immunopharmacology Ligand 14121 HER3-DXd, MK-1022, U3-1402
PBF-509 Immunopharmacology Ligand 10193 PBF509
PBT-3 Immunopharmacology Ligand 9755
PCA 4248 Immunopharmacology Ligand 6080 PCA-4248, PTEMC
pCXCL8-1aa Immunopharmacology Ligand 9938
PDE4 inhibitor 16 PDB Ligand Immunopharmacology Ligand 10400
pecazine Approved drug Immunopharmacology Ligand 9782 mepazine, nothiazine, Pacatal®
peficitinib Approved drug Immunopharmacology Ligand 8315 ASP015K, JNJ-54781532
pegcetacoplan Approved drug Immunopharmacology Ligand 13826 APL-2, Empaveli®
peginterferon alfa-2b Approved drug Immunopharmacology Ligand 7462 PegIntron®, Sylatron®
peginterferon beta-1a Approved drug Immunopharmacology Ligand 7637 interferon beta 1-alpha, PEG-INF-β-1a, Plegridy®
pelubiprofen Immunopharmacology Ligand 9876 compound 13b [PMID: 6607354], CS-670, DW-330SR, DW330SR, RS-2131
pembrolizumab Approved drug Immunopharmacology Ligand 7499 Keytruda®, lambrolizumab, MK-3475
penicillamine Approved drug PDB Ligand Immunopharmacology Ligand 7264 Cuprimine®
penpulimab Approved drug Immunopharmacology Ligand 12347 AK-105, AK105, Aniko®, penpulimab-kcqx
peptide Cp40 [PMID: 25982307] Immunopharmacology Ligand 9220 peptide 14
peptide 1 [PMID: 31774287] Immunopharmacology Ligand 10594
peptide 30 [PMID: 27019010] Immunopharmacology Ligand 9253
perenostobart Immunopharmacology Ligand 12103 SRF-617, SRF617
petesicatib Immunopharmacology Ligand 9855 RG-7625, RG7625, RO-5459072
PF-03715455 PDB Ligand Immunopharmacology Ligand 8179
PF-04191834 Immunopharmacology Ligand 9054 PF 4191834, PF-4191834
PF-04418948 Immunopharmacology Ligand 5817 PF 04418948, PF04418948
PF-04634817 Immunopharmacology Ligand 9979 example 13 [US8293903], PF-4634817, PF04634817, PF4634817
PF-04859989 Immunopharmacology Ligand 9038 compound 1 [PMID: 23466229]
PF-04905428 Immunopharmacology Ligand 9062 CE-224,535, CE-224535, compound 3 [PMID: 21782426], compound 33 [PMID: 21565499]
PF-04957325 Immunopharmacology Ligand 9659
PF-06263276 PDB Ligand Immunopharmacology Ligand 9432 compound 2 [PMID: 27983835], PF 0626327, PF0626327
PF-06282999 Immunopharmacology Ligand 10053 compound 8 [PMID: 26509551], PF06282999
PF-06426779 Immunopharmacology Ligand 9666 example 189 [WO2015150995], example 38 [PMID:28498658]
PF-06840003 Immunopharmacology Ligand 9565 EOS200271, PF06840003
PF‐06928215 Immunopharmacology Ligand 11324
PF-07038124 Immunopharmacology Ligand 11950 Example 4 [US2020108083A1], PF07038124
PF-07054894 Immunopharmacology Ligand 12765 PF07054894
PF-152 Immunopharmacology Ligand 9014 compound 43a, example 64 [WO2009016498], PF152
PFK15 Immunopharmacology Ligand 9562 PFK-015
PGE2 Approved drug PDB Ligand Immunopharmacology Ligand 1883 Cervidil®, minprositin E2, minprostin E2, Propess®, prostaglandin E2
PGF2α PDB Ligand Immunopharmacology Ligand 1884 prostaglandin F2α
PH-797804 PDB Ligand Immunopharmacology Ligand 7818
PHA-408 Immunopharmacology Ligand 9398 PHA408
phenylbutazone Approved drug PDB Ligand Immunopharmacology Ligand 7270 Butazolidine®
piclamilast PDB Ligand Immunopharmacology Ligand 11627 RP 73401, RP-73-401, RP73401
piclidenoson PDB Ligand Immunopharmacology Ligand 422 IB-MECA, CF 101, CF101, N(6)-ibamu
pirfenidone Approved drug Immunopharmacology Ligand 7532 AMR-69, Esbriet®
piroxicam Approved drug Immunopharmacology Ligand 7273 CP-16171, Feldene®
pirtobrutinib Approved drug PDB Ligand Immunopharmacology Ligand 11628 BTK inhibitor 16, Jaypirca®, LOXO-305, LOXO305, MCL-133, MCL133, RXC005
pixatimod Immunopharmacology Ligand 9870 compound 18 [PMID: 22458531], PG-545, PG545
PJ34 PDB Ligand Immunopharmacology Ligand 11348 PJ-34
PKCθ inhibitor 14 Immunopharmacology Ligand 9452 compound 14 [PMID: 27117263]
PKUMDL_MH_1001 Immunopharmacology Ligand 9141
plerixafor Approved drug PDB Ligand Immunopharmacology Ligand 844 AMD 3100, AMD3100, bicyclam JM-2987, JM 3100, Mozobil®
plonmarlimab Immunopharmacology Ligand 11644 TJ 003234, TJ003234, TJM2
plozalizumab Immunopharmacology Ligand 8921 hu1D9, MLN-1202, MLN1202
PLX5622 PDB Ligand Immunopharmacology Ligand 9105 PLX 5622, PLX-5622
PLX7486 Immunopharmacology Ligand 9104 OPN 7486, OPN-7486, PLX-7486
(S)-23 [PMID: 27933945] PDB Ligand Immunopharmacology Ligand 9796
PMX205 Immunopharmacology Ligand 5762 ALS-205, PMX 205, PMX-205
PN10 Immunopharmacology Ligand 10089
PO-322 Immunopharmacology Ligand 10739 1H-indole-2,3-dione 3-(1,3-benzoxazol-2-ylhydrazone), PO322
polatuzumab vedotin Approved drug Immunopharmacology Ligand 8404 ACD79B-VCMMAE, polatuzumab vedotin-piiq, Polivy®, RG-7596, RG7596, RO5541077-000
polmacoxib Approved drug PDB Ligand Immunopharmacology Ligand 8316 Acelex® (S. Korea), CG-100649, CG100649
pomalidomide Approved drug Immunopharmacology Ligand 7348 CC-4047, IMID-3, Imnovid®, Pomalyst®
POM2-C-HMBP Immunopharmacology Ligand 9616
ponatinib Approved drug PDB Ligand Immunopharmacology Ligand 5890 AP24534, Iclusig®
ponesimod Approved drug Immunopharmacology Ligand 9320 ACT-128800, ACT128800, Compound 8bo [PMID:20446681], Ponvory®
poseltinib Immunopharmacology Ligand 9862 Example 228 [WO2011162515A2], HM71224, HM‐71224, LY333764
povorcitinib Immunopharmacology Ligand 11881 compound 7 [US20210238168A1]
pozelimab Approved drug Immunopharmacology Ligand 12900 pozelimab-bbfg, REGN-3918, REGN3918, Veopoz®
PP2 Immunopharmacology Ligand 9404
PQA-18 Immunopharmacology Ligand 9454
praliciguat Immunopharmacology Ligand 9900 IW-1973, IW1973
pralnacasan Immunopharmacology Ligand 6467 VX-740, VX740
pranlukast Approved drug PDB Ligand Immunopharmacology Ligand 3634 ONO RS-411
prednicarbate Approved drug Immunopharmacology Ligand 7605 Dermatop®, Hoe 777, Hoe-777, S-770777
prednisolone Approved drug PDB Ligand Immunopharmacology Ligand 2866 DELTA.1-Cortisol, Orapred®, Pediapred®
prednisone Approved drug Immunopharmacology Ligand 7096 Lodotra®, Sterapred®
preladenant Immunopharmacology Ligand 5614 SCH-420814, SCH420814
PRN694 Immunopharmacology Ligand 9285
procaterol Approved drug Immunopharmacology Ligand 3464
programmed cell death 1 ligand 1 Immunopharmacology Ligand 9606 PD-L1, B7 homolog 1, B7-H1, PDL1, programmed death ligand 1
prolgolimab Immunopharmacology Ligand 12991 BCD-100, BCD100
proximod Immunopharmacology Ligand 13783 compound 53b [Tian et al., 2013], IMMH001, LJR001, SYL930
PSB1115 Immunopharmacology Ligand 3286 compound 17 [PMID: 11906291], PSB 1115, PSB-1115
PSB-17365 Immunopharmacology Ligand 9871 compound 48 [Pillaiyar et al., 2018], PSB17365
PSB-KD107 Immunopharmacology Ligand 11081 compound 2Ak [PMID: 17827019], compound 5 [Schoeder et al., 2020]
psora-4 Immunopharmacology Ligand 9583 5-(4-phenylbutoxy)psoralen, psora 4
PXS-4681A Immunopharmacology Ligand 9753
PXS-4728A Immunopharmacology Ligand 9346 PXS4728A
P2Y14R antagonist I-17 Immunopharmacology Ligand 13422 compound I-17 [PMID: 38874515]
2-pyridylethylamine Immunopharmacology Ligand 1197 PEA
 
Q Back to top
QAV680 Immunopharmacology Ligand 8996 NVP-QAV680
quavonlimab Immunopharmacology Ligand 13890 MK-1308, MK1308
quecitinib Immunopharmacology Ligand 14064 QY-201, QY201, VVN-461, VVN461
quemliclustat PDB Ligand Immunopharmacology Ligand 10707 AB-680, AB680
quilizumab Immunopharmacology Ligand 8998 47H4 v5 hulgG1, MEMP1972A, RG-7449
QWF Immunopharmacology Ligand 9568 Boc-Gln-D-Trp(CH0)-Phe-OBzl, Nα-[Nα-[Nα-(tert-butyloxycabonyl)-L-glutaminyl]-N1-formyl-D-tryptophyl-L-phenylalanine benzyl ester
 
R Back to top
1R-11 Immunopharmacology Ligand 10138
R283 Immunopharmacology Ligand 10049 1,3-Dimethyl-2[(oxopropyl)thio]imidazolium
RA839 PDB Ligand Immunopharmacology Ligand 10487 compound 7 [PMID: 31411465], RA-839
rabeximod Immunopharmacology Ligand 9856 Rob-803, Rob803
RANK ligand Immunopharmacology Ligand 5066 receptor activator of nuclear factor κB ligand, osteoclast differentiation factor (ODF), osteoprotegerin ligand, TNFSF11
ravulizumab Approved drug Immunopharmacology Ligand 10168 ALXN-1210, ALXN1210, ravulizumab-cwvz, Ultomiris®
rebastinib PDB Ligand Immunopharmacology Ligand 9173 DCC 2036, DCC-2036, DP-1919
relacorilant Immunopharmacology Ligand 13830 compound 7 [PMID: 28368581], CORT-125134, CORT125134
relatlimab Approved drug Immunopharmacology Ligand 9536 BMS-986016, BMS986016, ONO-4482, Opdualag® (nivolumab + relatlimab-rmbw), relatlimab-rmbw
remibrutinib Immunopharmacology Ligand 10457 compound 25 [PMID: 32083858], example 6 [WO2015079417A1], LOU-064, LOU064, LOU064-NXA, NVP-LOU064-NXA
remtolumab Immunopharmacology Ligand 9597 A-1230717, ABT-122
reparixin Immunopharmacology Ligand 8498 DF 1681Y, repertaxin
reproxalap Immunopharmacology Ligand 10613 ADX-102, ADX102, example 5 [WO2018039197A1], NS-2, NS2
resatorvid Immunopharmacology Ligand 9036 TAK-242, TAK242
resiquimod PDB Ligand Immunopharmacology Ligand 5051 R-848, R848
reslizumab Approved drug Immunopharmacology Ligand 8091 CDP-835, CDP835, Cinqaero®, Cinqair®, JES1-39D10, SCH55700
resolvin D1 Immunopharmacology Ligand 3934 RvD1, 7S,8R,17S‐trihydroxy‐4Z,9E,11E,13Z,15E,19Z‐docosahexaenoic acid
resolvin D2 Immunopharmacology Ligand 5417
[3H]resolvin D1 Ligand is labelled Ligand is radioactive Immunopharmacology Ligand 4356 [3H]-RvD1
resolvin E1 Immunopharmacology Ligand 3333 RvE1, 5S,12R,18R‐trihydroxy‐6Z,8E,10E,14Z,16E‐eicosapentaenoic acid
[3H]resolvin E1 Ligand is labelled Ligand is radioactive Immunopharmacology Ligand 2901 [(3)H]-labeled RvE1, [3H]RvE1
resveratrol PDB Ligand Immunopharmacology Ligand 8741 3,4',5-stilbenetriol, 3,5,4'-trihydroxystilbene, trans-resveratrol
retifanlimab Approved drug Immunopharmacology Ligand 11583 hPD-1 mAb 7(1.2), INCMGA0012, MGA012, retifanlimab-dlwr, Zynyz®
revamilast Immunopharmacology Ligand 9865 Example 26 [WO2006064355A2], GRC 4039, GRC-4039, GRC4039
RG7112 PDB Ligand Immunopharmacology Ligand 9599
rilapladib Immunopharmacology Ligand 7376 SB 659032
rilonacept Approved drug Immunopharmacology Ligand 6790 Arcalyst®, IL-1 Trap, interleukin-1 Trap
rilzabrutinib Approved drug PDB Ligand Immunopharmacology Ligand 9993 Example 31 [WO2014039899], PRN-1008, PRN1008, Wayrilz®
rimacalib Immunopharmacology Ligand 9364 SMP-114
rimexolone Approved drug Immunopharmacology Ligand 7099 ORG-6216, Vexol®
RIPA-56 Immunopharmacology Ligand 9643 compound 56 [PMID: 27992216], compound 92 [WO2016101885]
RIPK2 inhibitor 3 PDB Ligand Immunopharmacology Ligand 10413 compound 3 [PMID: 31265286], Example 1 [WO2014043446A1], GSK2983559
RIPK2 inhibitor 5 PDB Ligand Immunopharmacology Ligand 10419 compound 5 [PMID: 31265286]
RIPK2 inhibitor 8 Immunopharmacology Ligand 9688
RIPK3 inhibitor 18 PDB Ligand Immunopharmacology Ligand 10389
RIPK3 inhibitor 42 Immunopharmacology Ligand 10401
risankizumab Approved drug Immunopharmacology Ligand 8922 ABBV-066, BI 655066, BI-655066, risankizumab-rzaa, Skyrizi®
ritlecitinib Approved drug Immunopharmacology Ligand 9559 compound 11 [PMID: 28139931], example 5 [WO2015083028], Litfulo®, PF-06651600, PF06651600
rituximab Approved drug Immunopharmacology Ligand 6780 HSDB 7455, IDEC-C2B8, MabThera®, Rituxan®
Ro26-4550 Immunopharmacology Ligand 5052 Ro 26-4550, Ro-26-4550
rocatinlimab Immunopharmacology Ligand 13045 AMG-451, AMG451, KHK-4083, KHK4083
rocbrutinib Immunopharmacology Ligand 12875
rofecoxib Approved drug PDB Ligand Immunopharmacology Ligand 2893 Ceoxx®, MK 966, Vioxx®
roflumilast Approved drug PDB Ligand Immunopharmacology Ligand 6962 ARQ-151/Zoryve® (roflumilast cream), BY-217, BYK-20869, Daliresp®, Daxas®
roflupram Immunopharmacology Ligand 10691 FFPM, Zl-n-91
rolipram Immunopharmacology Ligand 5260 (±)-rolipram, (R,S)-rolipram
ROMe Immunopharmacology Ligand 6625 (R)-FTY720 methyl ether, (R)-FTY720-OMe
romiplostim Approved drug Immunopharmacology Ligand 6974 MG531, Nplate®
rontalizumab Immunopharmacology Ligand 9640 9F3v13, RhuMAB IFNalpha, rhuMAb interferon-α
RORC2 inverse agonist 66 [PMID: 30130103] Immunopharmacology Ligand 10078 example 5 [WO2016046755A1]
rosiptor Immunopharmacology Ligand 9249 AQX-1125, AQX1125
rovazolac Immunopharmacology Ligand 9625 A-110, ALX-101, example 36 [WO2013130892]
rovelizumab Immunopharmacology Ligand 9598 Hu23F2G, LeukArrest
rozanolixizumab Approved drug Immunopharmacology Ligand 9801 CA170_01519.g57 IgG4P, rozanolixizumab-noli, Rystiggo®, UCB-7665, UCB7665
RP-101075 Immunopharmacology Ligand 9889
RS-102895 PDB Ligand Immunopharmacology Ligand 779 abaucin, RS102895
RS-504393 Immunopharmacology Ligand 781 RS 504393, RS504393
RSLV-132 Immunopharmacology Ligand 10412 RSLV132
rupatadine Approved drug Immunopharmacology Ligand 10103 Rinialer®, Rupafin®, UR-12592, UR12592
ruxolitinib Approved drug PDB Ligand Immunopharmacology Ligand 5688 (R)-ruxolitinib, INC424, INCB 18424, INCB018424, Jakafi®, Jakavi®
RV1729 Immunopharmacology Ligand 10162 RV-1729
RV6153 Immunopharmacology Ligand 10163 RV-6153
RvD1-ME Immunopharmacology Ligand 5555 RvD1-methyl ester
RWJ-56423 PDB Ligand Immunopharmacology Ligand 9333 (2S)-6
 
S Back to top
S4-1 Immunopharmacology Ligand 12321
salbutamol Approved drug Immunopharmacology Ligand 558 albuterol, SCH-13949W, Ventolin®
salicylic acid Approved drug PDB Ligand Immunopharmacology Ligand 4306 Bazuka Extra Strength Gel®, salicylate
salmeterol Approved drug Immunopharmacology Ligand 559 GR 33343X, Serevent®
salvianolic acid A Immunopharmacology Ligand 13093 Dan Phenolic Acid A, Danshen, Sal A
Sanofi-14h Immunopharmacology Ligand 13067 compound 14h [PMID: 25589934]
sapropterin Approved drug PDB Ligand Immunopharmacology Ligand 5276 Kuvan®, sapropterin dihydrochloride, SUN-0588, T-1401, tetrahydrobiopterin (THB)
SAR-20347 Immunopharmacology Ligand 9803
sarilumab Approved drug Immunopharmacology Ligand 7999 Kevzara®, REGN88, SAR153191
satralizumab Approved drug Immunopharmacology Ligand 9093 Enspryng®, RG-6168, RG6168, SA-237, SA237, sapelizumab (deprecated INN), satralizumab-mwge
SB202190 PDB Ligand Immunopharmacology Ligand 4307 SB 202190, SB-202190
SB203580 Immunopharmacology Ligand 5269 PB 203580, RWJ 64809, SB-203580
SB 225002 Immunopharmacology Ligand 833 SB-225002, SB225002
SB290157 Immunopharmacology Ligand 3529 SB-290157
SB328437 Immunopharmacology Ligand 3530 SB 328437, SB-328437
SC-51089 Immunopharmacology Ligand 1923 SC 51089
SC-67655 Immunopharmacology Ligand 8889
Sch.336 Immunopharmacology Ligand 9799 analog 4j [PMID: 15664857], SCH-336, SCH336
SD-208 Immunopharmacology Ligand 8246 SCI-208, SD 208
S-26d [PMID: 37883692] Immunopharmacology Ligand 12979
secukinumab Approved drug Immunopharmacology Ligand 8078 AIN 457, AIN457, Cosentyx®, NVP-AIN457
selectin P ligand Immunopharmacology Ligand 10014
seletalisib Immunopharmacology Ligand 9800 UCB 5857, UCB-5857, UCB5857
selinexor Approved drug Immunopharmacology Ligand 10036 compound 70 [WO2013019561A1], KPT-330, KPT330, Nexpovio®, Xpovio®
selnoflast Immunopharmacology Ligand 12173 Example 6 [WO2019008025A1], RG-6418, RG6418
selonsertib PDB Ligand Immunopharmacology Ligand 9040 GS-4997
semaphorin 3A Immunopharmacology Ligand 9902
S-EMCA PDB Ligand Immunopharmacology Ligand 7048 6α-ethyl-23(S)-methyl-cholic acid, INT-777, INT777
seniprutug Approved drug Immunopharmacology Ligand 13939 BCD-180, BCD180
serlopitant Immunopharmacology Ligand 9280 compound 17 (Jiang et al. 2009), VPD-737
serplulimab Approved drug Immunopharmacology Ligand 13796 HANSIZHUANG® (China), Hetronifly®, HLX-10, HLX10
setanaxib Immunopharmacology Ligand 9932 GKT-137831, GKT-831, GKT137831, GKT831
setipiprant Immunopharmacology Ligand 10180 ACT-129968, ACT129968, compound 28 [PMID: 23721423]
setogepram Immunopharmacology Ligand 10043 3-pentylbenzeneacetic acid, fezagepras, PBI-4050, PBI4050
SGC-CBP30 PDB Ligand Immunopharmacology Ligand Antimalarial Ligand 7529
SIAIS178 Immunopharmacology Ligand 10526 compound 19 [PMID: 31539241], SIAIS-178
sibeprenlimab Immunopharmacology Ligand 12102 VIS-649, VIS649
sifalimumab Immunopharmacology Ligand 8257 MDX-1103, MEDI-545, MEDI545
siltuximab Approved drug Immunopharmacology Ligand 7396 cLLB8, CNTO 328, Sylvant®
sintilimab Approved drug Immunopharmacology Ligand 12990 IBI 308, IBI-308, IBI308, Tyvyt®
siponimod Approved drug PDB Ligand Immunopharmacology Ligand 9289 BAF-312, BAF312, compound 32 [PMID: 24900670], Mayzent®
sirolimus Approved drug PDB Ligand Immunopharmacology Ligand 6031 AY-22989, Fyarro® (sirolimus albumin-bound particles), Rapamune®, rapamycin, WY-090217
SIRT1 activator 3 Immunopharmacology Ligand 9514 SA-3, SA3
sirukumab Immunopharmacology Ligand 7989 CNTO 136, CNTO-136, Plivensia (proposed trade name)
SLM6071469 Immunopharmacology Ligand 10641 compound 10 [PMID: 31895563]
SNG001 Immunopharmacology Ligand 11129
SNX0723 PDB Ligand Immunopharmacology Ligand 9260
sofnobrutinib Immunopharmacology Ligand 10094 compound 4b [PMID: 30216722]
solcitinib Immunopharmacology Ligand 9697 compound 1 [WO2010149771], GLPG-0778, GLPG0778, GSK2586184
sonelokimab Immunopharmacology Ligand 10491 IL17-MS3086, IL17MS3086, SEQ ID 836 [WO2012156219A1]
sotrastaurin PDB Ligand Immunopharmacology Ligand 7946 AEB-071, AEB071
sotuletinib Immunopharmacology Ligand 8250 BLZ 945, BLZ-945, BLZ945
SP-4206 PDB Ligand Immunopharmacology Ligand 9037 compound 13 [PMID:12656598], SP4206
SP600125 PDB Ligand Immunopharmacology Ligand 5273 1,9-pyrazoloanthrone, JNK Inhibitor II, SP-600125
sparsentan Approved drug Immunopharmacology Ligand 8448 DARA-a (Dual Acting Receptor Antagonist of angiotension and endothelin receptors), BMS-346567, compound 7 [PMID 15634011], Filspari®, RE-021, retrophin
spartalizumab Immunopharmacology Ligand 10140 NPV-PDR001, NPVPDR001, PDR-001, PDR001
spebrutinib Immunopharmacology Ligand 7837 AVL 292, AVL-292, cc-292
spesolimab Approved drug Immunopharmacology Ligand 12169 BI-655130, BI655130, spesolimab-sbzo, Spevigo®
sphingomyelin synthase 2 inhibitor 15w Immunopharmacology Ligand 10054 compound 15w [PMID: 30074791]
SPRi3 PDB Ligand Immunopharmacology Ligand 10130 example 23 [WO2011047156], SPR inhibitor 3
SR1001 Immunopharmacology Ligand 10143 SR-1001
SR144528 Immunopharmacology Ligand 751 SR 144528, SR-144528
SR1555 Immunopharmacology Ligand 10145 SR-1555
SR2211 PDB Ligand Immunopharmacology Ligand 10144 SR-2211
SR2640 Immunopharmacology Ligand 3329 SR 2640, SR-2640
SR8185 Immunopharmacology Ligand 9578 SR-8185
18S-resolvin E1 Immunopharmacology Ligand 5106 18S-RvE1
SRT1720 PDB Ligand Immunopharmacology Ligand 7703
SRT2104 Immunopharmacology Ligand 9515 compound 4 [Ng et al., 2013], GSK2245840, SRT-2104
SS-208 PDB Ligand Immunopharmacology Ligand 10490 compound 7b [PMID: 31414801], SS208
stapokibart Approved drug Immunopharmacology Ligand 13785 CM-310, CM310
stem cell factor Immunopharmacology Ligand 5055 SCF, c-Kit ligand
STING agonist 2 PDB Ligand Immunopharmacology Ligand 10127
STING agonist 3 PDB Ligand Immunopharmacology Ligand 10128 compound 3 [PMID: 30405246], diABZI, diABZI STING agonist-1
(R)-STU104 Immunopharmacology Ligand 12006 (R)-4e [PMID: 35442672]
sulindac Approved drug Immunopharmacology Ligand 5425 Clinoril®
suprofen Approved drug Immunopharmacology Ligand 7298 Profenal®, R-25061
sutimlimab Approved drug Immunopharmacology Ligand 9807 BIVV009, Enjaymo®, IPN-009, IPN009, sutimlimab-jome, TNT009
SX682 Immunopharmacology Ligand 10165
Syk inhibitor Immunopharmacology Ligand 6046 K00564a, spleen tyrosine kinase inhibitor
Syk inhibitor II Immunopharmacology Ligand 6047 K00592a
SZM679 Immunopharmacology Ligand 12311 SZM-679
 
T Back to top
T0901317 PDB Ligand Immunopharmacology Ligand 2755 T 0901317, T-0901317
tabalumab Immunopharmacology Ligand 8000 LY 2127399, LY2127399
tadekinig alfa Immunopharmacology Ligand 10077
tafasitamab Approved drug Immunopharmacology Ligand 11131 Minjuvi®, Monjuvi®, MOR-208, MOR00208, MOR208, tafasitamab-cxix, Xmab5574
tagitanlimab Approved drug Immunopharmacology Ligand 13795 A-167, Cotelet®, HBM-9167, KL-A167, KLA167
TAK-632 PDB Ligand Immunopharmacology Ligand 10387 compound 8B [PMID: 23906342], TAK632
TAK-715 PDB Ligand Immunopharmacology Ligand 9328 compound 8h [PMID: 16162000], TAK 715, TAK0715
TAK-779 Immunopharmacology Ligand 783 TAK779
TAK-981 Immunopharmacology Ligand 11305 Example 133 [WO2016004136A1], I-263a [WO2016004136A1], subasumstat (proposed INN), TAK981
TAK-828F PDB Ligand Immunopharmacology Ligand 9867 compound 10 [PMID: 29510038], TAK-828, TAK828F
Takinib PDB Ligand Immunopharmacology Ligand 9655
talabostat Immunopharmacology Ligand 9892 compound 1 [PMID: 18783201], PT-100, PT100, Val-boro-pro, Val-boroPro
talmapimod PDB Ligand Immunopharmacology Ligand 7817 SCIO 469 hydrochloride, SCIO-469
tamatinib PDB Ligand Immunopharmacology Ligand 5706 R 406, R-406, R406 free base
tanespimycin Immunopharmacology Ligand 7751 17-AAG, 17-allylamino-17-demethoxygeldanamycin, 17-N-allylamino-17-demethoxygeldanamycin, 17AAG, compound 4 [PMID:15978816]
tanzisertib Immunopharmacology Ligand 9836 CC-930, CC930, compound 1 [PMID: 22244937]
tapinarof Approved drug PDB Ligand Immunopharmacology Ligand 9686 benvitimod, GSK-2894512, GSK2894512, Vtama®, WB-1001, WBI 1001, WBI-1001
TAS05567 Immunopharmacology Ligand 9941
tauroursodeoxycholic acid Approved drug PDB Ligand Immunopharmacology Ligand 4746 TUDA, Relyvrio® (sodium phenylbutyrate + taurursodiol), tauroursodeoxycholate, taurursodiol, TUDCA, UR 906, ursodoxicoltaurine (INN)
TC14012 Immunopharmacology Ligand 2902 TC 14012, TC-14012
tebentafusp Approved drug Immunopharmacology Ligand 7378 IMCgp100, Kimmtrak®, tebentafusp-tebn
teduglutide Approved drug Immunopharmacology Ligand 7049 ALX-0600, Gattex®, GLP2-2G, Revestive®
telitacicept Approved drug Immunopharmacology Ligand 11827 RC18, Tai'ai®
telotristat ethyl Approved drug Immunopharmacology Ligand 9490 LX-1606, LX1606, Xermelo®
temelimab Immunopharmacology Ligand 11530 GNbAC1
tenalisib Immunopharmacology Ligand 9907 RP-6530, RP6530
teneligliptin Approved drug PDB Ligand Immunopharmacology Ligand 9906 compound 8g [PMID: 22959556], MP-513, MP513, Teneli
tepilamide fumarate Immunopharmacology Ligand 9770 XP 23829, XP-23829, XP23829
teplizumab Approved drug Immunopharmacology Ligand 12252 humanized OKT3, MGA031, PRV-031, teplizumab-mzwv, Tzield®
tepoditamab Immunopharmacology Ligand 10353 MCLA-117, MCLA117, PB9122
TEPP-46 Immunopharmacology Ligand 10555 compound 46 [PMID: 20451379], ML-265, ML265, TEPP46
teprotumumab Approved drug Immunopharmacology Ligand 10612 R1507, RG-1507, RG1507, RV 001, RV-001, Tepezza®, teprotumumab-trbw
terfenadine Approved drug Immunopharmacology Ligand 2608 RMI-9918, Seldane®, Triludan®
teriflunomide Approved drug PDB Ligand Immunopharmacology Ligand 6844 A77 1726, Aubagio®, flucyamide, HMR-1726
tethered chemerin 9 Immunopharmacology Ligand 9784
tetomilast Immunopharmacology Ligand 9877 compound 19f [PMID: 7830278], OPC-6535, OPC6535
tezepelumab Approved drug Immunopharmacology Ligand 8933 AMG 157, AMG-157, MEDI-9929, MEDI9929, tezepelumab-ekko, Tezspire®
TG11-77 Immunopharmacology Ligand 10603 compound 20o [PMID: 31904232]
TG6-129 Immunopharmacology Ligand 9283
TG8-260 Immunopharmacology Ligand 12520 compound 2f [PMID: 35187419], TG8260
TGFβ1 Immunopharmacology Ligand 5060 TGF-beta-1, transforming growth factor beta-1
TH5487 PDB Ligand Immunopharmacology Ligand 10184 TH-5487
thalidomide Approved drug Immunopharmacology Ligand 7327 K-17
theophylline Approved drug PDB Ligand Immunopharmacology Ligand 413 Nuelin®, Slo-Bid®, Theolair®
thrombospondin 1 Immunopharmacology Ligand 13047 THBS-1, TSP-1, TSP1
thymic stromal lymphopoietin Immunopharmacology Ligand 5083 TSLP
tibulizumab Immunopharmacology Ligand 10350 LY-3090106, LY3090106
tigemocoxib PDB Ligand Immunopharmacology Ligand 13505 29b-(S) [PMID: 20709553], SC-75416, SC75416
tildrakizumab Approved drug Immunopharmacology Ligand 8093 Ilumetri®, Ilumya®, MK-3222, MK3222, SCH-900222, SCH900222, SUNPG1623, tildrakizumab-asmn
timapiprant Immunopharmacology Ligand 9277 OC000459, OC459
timolumab Immunopharmacology Ligand 9097 8c10, BTT-1023, BTT1023, r8c10, SI-3106, SI-636
tiotropium Approved drug Immunopharmacology Ligand 367 BA-679-BR, Spiriva®
tirabrutinib Approved drug PDB Ligand Immunopharmacology Ligand 9265 GS-4059, ONO-4059, ONO4059, Velexbru®
tislelizumab Approved drug Immunopharmacology Ligand 9592 Bai Zean®, BGB-A317, BGBA317, hu317-1/IgG4mt2, Tevimbra®, tislelizumab-jsgr
TK05 Immunopharmacology Ligand 9556
TL6 Immunopharmacology Ligand 5072 activation-inducible TNF-related ligand, glucocorticoid- induced TNF-related ligand
TL1A Immunopharmacology Ligand 5071 Tumor necrosis factor ligand superfamily member 15, membrane form
TM30089 Immunopharmacology Ligand 1905 CAY 10471, CAY-10471, CAY10471
tocilizumab Approved drug Immunopharmacology Ligand 6881 Actemra®, R-1569, RG-1569, RHPM-1, RoActemra®
toddacoumalone Immunopharmacology Ligand 13467 compound 8 [PMID: 24597921]
tofacitinib Approved drug PDB Ligand Immunopharmacology Ligand 5677 CP-690,550, CP-690550, tasocitinib, Xeljanz®
tolebrutinib Immunopharmacology Ligand 10625 BTK'168, example 3 [WO2016196840A1], PRN-2246, PRN2246, SAR442168
tolmetin Approved drug PDB Ligand Immunopharmacology Ligand 7311 MCN-2559, McN-2559-21-98, Tolectin®
tomaralimab Immunopharmacology Ligand 9408 OPN-305, OPN305, VK5A/H4
tomivosertib PDB Ligand Immunopharmacology Ligand 10167 compound 23 [PMID: 29526098], eFT-508, eFT508
toreforant Immunopharmacology Ligand 9276 JNJ-38518168
toripalimab Approved drug Immunopharmacology Ligand 12989 JS-001, JS001, Loqtorzi®, toripalimab-tpzi
tositumomab Approved drug Immunopharmacology Ligand 6781 Bexxar®, V10XA53
tozorakimab Immunopharmacology Ligand 12964 MEDI-3506, MEDI3506
tradipitant Immunopharmacology Ligand 9278 LY-686017, LY686017, VLY-686
tralokinumab Approved drug Immunopharmacology Ligand 8001 Adbry®, Adtralza®, BAK1.1, CAT-354, tralokinumab-ldrm
TRAM-34 Immunopharmacology Ligand 2336
tranilast Approved drug PDB Ligand Immunopharmacology Ligand 6326 MK-341, SB-252218
tregalizumab Immunopharmacology Ligand 9864 BT-061, hB-F5
tremelimumab Approved drug Immunopharmacology Ligand 8462 CP-675, CP-675,206, CP-675206, Imjudo®, ticilimumab, tremelimumab-actl
triamcinolone Approved drug Immunopharmacology Ligand 2870 fluoxiprednisolone, Kenalog®, Nasacort®
triamcinolone acetonide Approved drug PDB Ligand Immunopharmacology Ligand 2867 Zilretta®
trifarotene Approved drug PDB Ligand Immunopharmacology Ligand 9962 Aklief®, CD5789, compound 15b [PMID: 29706423]
trilaciclib Approved drug Immunopharmacology Ligand 9626 Cosela®, G1T28
trilobatin Immunopharmacology Ligand 13073 phloretin-4'-O-glucoside, prunin dihydrochalcone
tripelennamine Approved drug Immunopharmacology Ligand 7318 Pyribenzamine®
triple modulator 10 [PMID: 29878767] Immunopharmacology Ligand 10002
tryptanthrin 5i Immunopharmacology Ligand 10126 compound 5i [PMID: 24099220]
tubastatin A PDB Ligand Immunopharmacology Ligand 9702
TUG-1375 Immunopharmacology Ligand 10107 compound 31 [PMID: 30247908], TUG1375
TUG-2181 Immunopharmacology Ligand 13892 compound 40g [PMID: 40183744], compound I-319 [WO2022167445A1], TUG2181
tumour necrosis factor membrane form Immunopharmacology Ligand 5073 TNF membrane form, cachectin, necrosin, TNFα
tumour necrosis factor shed form Immunopharmacology Ligand 5074 TNF shed form, cachectin, necrosin, TNF alpha soluble form, tumor necrosis factor soluble form
TY-51469 Immunopharmacology Ligand 9779
TYD-68 Immunopharmacology Ligand 13823 TYK2 PROTAC 15t [PMID: 40116635]
TYK2 inhibitor 14l Immunopharmacology Ligand 11425
 
U Back to top
U46619 PDB Ligand Immunopharmacology Ligand 1888 11α,9α-epoxymethano-PGH2, U 46619, U-46619
ublituximab Approved drug Immunopharmacology Ligand 8920 Briumvi®, LFB-R603, TG-1101, TGTX-1101, ublituximab-xiiy
UCB-9260 Immunopharmacology Ligand 13912 UCB9260
ulinastatin Approved drug Immunopharmacology Ligand 10359 Miraclid®, Ulinase®, Urinastatin®
ulocuplumab Immunopharmacology Ligand 9161 BMS-936564, MDX-1338
umbralisib Approved drug Immunopharmacology Ligand 8916 example A1 [US2014011819], RP-5264, RP5264, TGR-1202, TGR1202, Ukoniq®
umeclidinium Approved drug Immunopharmacology Ligand 7354 GSK573719A, Incruse Ellipta®
UNC4203 Immunopharmacology Ligand 10131 MERTK inhibitor 19 [PMID: 30347155], UNC4203A [US20150291606A1]
upadacitinib Approved drug Immunopharmacology Ligand 9246 ABT-494, Rinvoq®
uracil 20 Immunopharmacology Ligand 9901
urelumab Immunopharmacology Ligand 9311 BMS 663513, BMS-663513
usnoflast Immunopharmacology Ligand 12883 Example-6 [WO2020148619A1], ZY-IL1, ZYIL-1, ZYIL1
ustekinumab Approved drug Immunopharmacology Ligand 6885 CNTO-1275, L04AC05, Stelara®, TT-20
utomilumab Immunopharmacology Ligand 9244 PF-05082566
 
V Back to top
vactosertib PDB Ligand Immunopharmacology Ligand 8107 EW-7197, EW7197, NOV-1301, TEW-7197
vadastuximab talirine Immunopharmacology Ligand 9434 SGN-CD33A
valategrast Immunopharmacology Ligand 11487 R-411, RO-0272441
valdecoxib Approved drug PDB Ligand Immunopharmacology Ligand 2894 Bextra®, SC-65872
vamorolone Approved drug Immunopharmacology Ligand 9247 Agamree®, VBP-15, VBP15
vanin-1 inhibitor [PMID: 33196323] Immunopharmacology Ligand 11718 example 1 [WO2016193844A1]
varespladib PDB Ligand Immunopharmacology Ligand 9657 compound 6m [PMID: 8978844], LY315920, S-5920, varespladib methyl (A-002), varespladib sodium (A-001)
varokibart Immunopharmacology Ligand 12187
VCE-004.3 Immunopharmacology Ligand 10030
vecabrutinib Immunopharmacology Ligand 10231 BIIB-062, BIIB062, SNS-062, SNS062
vedolizumab Approved drug Immunopharmacology Ligand 7437 Entyvio®, LDP-02, LDP02, MLN-0002, MLN-002, MLN002
velsecorat PDB Ligand Immunopharmacology Ligand 9325 AZ13189620, AZD7594, compound 15m [PMID: 28937774]
veltuzumab Immunopharmacology Ligand 8268 hA20, IMMU-106
vemurafenib Approved drug PDB Ligand Immunopharmacology Ligand 5893 PLX4032, RG7204, Zelboraf®
venetoclax Approved drug PDB Ligand Immunopharmacology Ligand 8318 ABT-199, GDC-0199, Venclexta®, Venclyxto®
vercirnon PDB Ligand Immunopharmacology Ligand 9046 CCX282-B, GSK'786, GSK1605786, GSK1605786A, Traficet-EN
verdiperstat PDB Ligand Immunopharmacology Ligand 10052 AZD-3241, AZD3241
verlukast Immunopharmacology Ligand 6193 MK-679, MK679
vidofludimus PDB Ligand Immunopharmacology Ligand 9860 4SC-101, IMU-838 (vidofludimus calcium), SC12267
vidupiprant Immunopharmacology Ligand 10169 AMG 853, AMG-853, AMG853, compound 2 [PMID: 24900313]
vilanterol Approved drug Immunopharmacology Ligand 7353 GW642444X
vimnerixin Immunopharmacology Ligand 12100 AZD-4721, AZD4721, compound 4 [WO2019055509A1], RIST4721
VIP Immunopharmacology Ligand 1152
vipadenant PDB Ligand Immunopharmacology Ligand 5612 BIIB 014, BIIB014, V2006
vipoglanstat Immunopharmacology Ligand 12209 BI 1029539, BI-1029539, BI1029539, GS-248, GS248
vixarelimab Immunopharmacology Ligand 13451 KPL-716, KPL716
Vm24 Immunopharmacology Ligand 10050 α-KTx 23.1
vobarilizumab Immunopharmacology Ligand 8363 ALX-0061
voclosporin Approved drug Immunopharmacology Ligand 11388 1,11-anhydro[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl- N-methyl-L-valyl-[(2S,3R,4R,6E)-3-hydroxy-4-methyl- 2-(methylamino)nona-6,8-dienoyl][(2S)-2-aminobutanoyl]- N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine], E-ISA247, ISA(TX)247, ISA-247, ISA247, ISATX247, Lupkynis®, R 1524, R-1524, R1524
vortioxetine Approved drug PDB Ligand Immunopharmacology Ligand 7351 Brintellix®, compound 5m [PMID: 21486038], Lu AA21004, Trintellix®
VRT-043198 PDB Ligand Immunopharmacology Ligand 9034
vunakizumab Approved drug Immunopharmacology Ligand 9296 AnDajing (Chinese trade name), SHR-1314
VX-702 Immunopharmacology Ligand 6059 I14-1965, VX 702, VX702
 
W Back to top
1400W PDB Ligand Immunopharmacology Ligand 5102 W 1400
WH-4-023 Immunopharmacology Ligand 8068
WJYK50 Immunopharmacology Ligand 10639 compound 1c [PMID: 29649738]
WKYMVm Immunopharmacology Ligand 1048 Trp-Lys-Tyr-Met-Val-[D]Met, WKYMVM
WN1703 Immunopharmacology Ligand 13463 compound 16c [PMID: 28918097], WN-1703, XOR inhibitor 16c
WRWWWW Immunopharmacology Ligand 1040 WRW4
WXFL10203614 Immunopharmacology Ligand 12621 WX614, WXFL-10203614
 
X Back to top
XCL1 Immunopharmacology Ligand 4447 lymphotactin-α
XCL1 Immunopharmacology Ligand 4446 lymphotactin-α
XCL1 Immunopharmacology Ligand 3647 c motif cytokine 1, cytokine SCM-1α, lymphotactin α
XCL2 Immunopharmacology Ligand 4370 C motif cytokine 2, lymphotactin β
xeligekimab Approved drug Immunopharmacology Ligand 13784 GR-1501, GR1501
Xilonix TN Immunopharmacology Ligand 8528
 
Y Back to top
YH35324 Immunopharmacology Ligand 13448 IgETRAP, YH-35324
YM90709 Immunopharmacology Ligand 5090 YM 90709, YM-90709
 
Z Back to top
zabedosertib Immunopharmacology Ligand 11415 BAY-1834845, BAY1834845
zadoprubart Immunopharmacology Ligand 13799
zafirlukast Approved drug PDB Ligand Immunopharmacology Ligand 3322 Accolate®, ICI-204219
zaloglanstat Immunopharmacology Ligand 11406
zanubrutinib Approved drug Immunopharmacology Ligand 9861 BGB-3111, BGB3111, Brukinsa®, compound 27b [US9447106]
zasocitinib PDB Ligand Immunopharmacology Ligand 12155 compound I-908 [US20190256519A1], NDI-034858, NDI034858, TAK-279, TAK279
zaurategrast Immunopharmacology Ligand 11488 CDP-323, CDP323
zegocractin Immunopharmacology Ligand 10087 Auxora, CM-4620, CM4620, compound I [WO2016138472A1]
zelebrudomide Immunopharmacology Ligand 13490 compound 28 [PMID: 38300987], NX-2127, NX2127
zelnecirnon Immunopharmacology Ligand 12893 example 37 [WO2019147862A1], RPT-193, RPT193
zemprocitinib Immunopharmacology Ligand 13221 compound 1 [US20220009927]
zenuzolac Immunopharmacology Ligand 11682 (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, GIT-027, GIT-27, GIT27, GLS-1027, GLS1027, rac-[(5R)-3-phenyl-4,5-dihydro-1,2-oxazol-5-yl]acetic acid, VGX-1027, VGX1027
zetomipzomib Immunopharmacology Ligand 10409 compound 12 [PMID: 30380863], KZR-616, KZR616
Z-FA-FMK Immunopharmacology Ligand 11257 MDL 201053, MDL-201053, MDL201053, Z-Phe-DL-Ala-fluoromethylketone, ZFA-fmk
zigakibart Immunopharmacology Ligand 12101 BION-1301, BION1301, clone 14_1G.15
zileuton Approved drug Immunopharmacology Ligand 5297 A-64077, ZYFLO®
ziltivekimab Immunopharmacology Ligand 11552 COR-001, COR001, MEDI-5117, MEDI5117, ZILTI
zilucoplan Approved drug Immunopharmacology Ligand 10404 RA-101495, RA101495, Zilbrysq®
zimberelimab Approved drug Immunopharmacology Ligand 12349 AB-122, AB122, GLS-010
zimlovisertib PDB Ligand Immunopharmacology Ligand 9667 compound 40 [PMID: 28498658], PF-06650833, PF06650833
(R)-ZINC-3573 PDB Ligand Immunopharmacology Ligand 9566 ZINC-72453573
ziritaxestat PDB Ligand Immunopharmacology Ligand 9561 compound 11 [PMID: 28414242], GLPG-1690, GLPG1690
ZK 756326 PDB Ligand Immunopharmacology Ligand 813 ZK-756326, ZK756326
ZLN005 Immunopharmacology Ligand 13255 ZLN 005, ZLN-005
zomiradomide Immunopharmacology Ligand 11904 compound A [WO2022027058A1]
ZSA-215 Immunopharmacology Ligand 13969 compound 2dr [PMID: 40442142], ZSA215